Olo (OLO) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-40213
Entity Registrant Name	Olo Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2971562
Entity Address, Address Line One	285 Fulton Street
Entity Address, Address Line Two	One World Trade Center
Entity Address, Address Line Three	82nd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10007
City Area Code	212
Local Phone Number	260-0895
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	OLO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001431695
Amendment Flag	false
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Common Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		105,945,207
Common Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		57,460,687

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 366,399	$ 514,445
Short-term investments	101,956	0
Accounts receivable, net of allowances of $612 and $657, respectively	43,108	42,319
Contract assets	402	568
Deferred contract costs	2,729	2,567
Prepaid expenses and other current assets	6,644	5,718
Total current assets	521,238	565,617
Property and equipment, net	10,540	3,304
Intangible assets, net	22,688	19,635
Goodwill	207,540	162,956
Contract assets, noncurrent	619	387
Deferred contract costs, noncurrent	3,991	3,616
Operating lease right-of-use assets	14,568	0
Long-term investments	804	0
Other assets, noncurrent	452	361
Total assets	782,440	755,876
Current liabilities:
Accounts payable	1,930	2,184
Accrued expenses and other current liabilities	46,543	45,395
Unearned revenue	2,608	1,190
Operating lease liabilities, current	2,666	0
Total current liabilities	53,747	48,769
Unearned revenue, noncurrent	1,121	3,014
Operating lease liabilities, noncurrent	16,328	0
Other liabilities, noncurrent	243	2,343
Total liabilities	71,439	54,126
Commitments and contingencies (Note 16)
Stockholders’ equity:
Class A common stock, $0.001 par value; 1,700,000,000 shares authorized at September 30, 2022 and December 31, 2021; 105,063,706 and 78,550,530 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively. Class B common stock, $0.001 par value; 185,000,000 shares authorized at September 30, 2022 and December 31, 2021; 58,421,140 and 79,149,659 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	163	158
Preferred stock, $0.001 par value; 20,000,000 shares authorized at September 30, 2022 and December 31, 2021	0	0
Additional paid-in capital	860,574	813,166
Accumulated deficit	(149,316)	(111,574)
Accumulated other comprehensive loss	(420)	0
Total stockholders’ equity	711,001	701,750
Total liabilities and stockholders’ equity	$ 782,440	$ 755,876

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Accounts receivable, net of allowance	$ 612	$ 657
Preferred stock, par value (in USD per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Common Class A
Common stock, par value (in USD per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,700,000,000	1,700,000,000
Common stock, shares issued (in shares)	105,063,706	78,550,530
Common stock, shares outstanding (in shares)	105,063,706	78,550,530
Common Class B
Common stock, par value (in USD per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	185,000,000	185,000,000
Common stock, shares issued (in shares)	58,421,140	79,149,659
Common stock, shares outstanding (in shares)	58,421,140	79,149,659

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue:	$ 47,266	$ 37,390	$ 135,623	$ 109,409
Cost of revenue:	15,266	8,164	42,236	22,377
Gross Profit	32,000	29,226	93,387	87,032
Operating expenses:
Research and development	19,101	14,485	53,159	42,872
General and administrative	20,894	21,270	56,090	53,034
Sales and marketing	7,923	4,728	24,890	12,265
Total operating expenses	47,918	40,483	134,139	108,171
Loss from operations	(15,918)	(11,257)	(40,752)	(21,139)
Other income (expenses), net:
Interest income	1,525	0	2,110	0
Interest expense	(70)	0	(116)	0
Other (expense) income	(7)	(15)	6	(23)
Change in fair value of warrant liability	0	0	0	(18,930)
Total other income (expenses), net	1,448	(15)	2,000	(18,953)
Loss before income taxes	(14,470)	(11,272)	(38,752)	(40,092)
Provision (benefit) for income taxes	90	36	(1,010)	110
Net loss	(14,560)	(11,308)	(37,742)	(40,202)
Accretion of redeemable convertible preferred stock to redemption value	0	0	0	(14)
Net loss attributable to Class A and Class B common stockholders	$ (14,560)	$ (11,308)	$ (37,742)	$ (40,216)
Net loss per share attributable to Class A and Class B common stockholders:
Basic (in USD per share)	$ (0.09)	$ (0.08)	$ (0.23)	$ (0.35)
Diluted (in USD per share)	$ (0.09)	$ (0.08)	$ (0.23)	$ (0.35)
Weighted-average Class A and Class B common shares outstanding:
Basic (in shares)	162,364,654	148,452,987	160,667,412	113,451,378
Diluted (in shares)	162,364,654	148,452,987	160,667,412	113,451,378
Platform
Revenue:	$ 46,357	$ 36,084	$ 132,361	$ 105,533
Cost of revenue:	13,920	6,632	37,693	18,419
Professional services and other
Revenue:	909	1,306	3,262	3,876
Cost of revenue:	$ 1,346	$ 1,532	$ 4,543	$ 3,958

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (14,560)	$ (11,308)	$ (37,742)	$ (40,202)
Other comprehensive loss:
Unrealized loss on investments	(169)	0	(420)	0
Total other comprehensive loss	(169)	0	(420)	0
Comprehensive income (loss)	$ (14,729)	$ (11,308)	$ (38,162)	$ (40,202)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Class A and Class B Common Stock	Additional Paid In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Temporary equity, shares outstanding at beginning of period (in shares) at Dec. 31, 2020	58,962,749
Temporary equity, value of shares outstanding at beginning of period at Dec. 31, 2020	$ 111,737
Redeemable Convertible Preferred Stock
Accretion of redeemable convertible preferred stock to redemption value	$ 14
Issuance of preferred stock on exercises of warrants (in shares)	1,681,848
Issuance of preferred stock on exercise of warrants	$ 2
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	(60,644,597)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ (111,753)
Temporary equity, shares outstanding at end of period (in shares) at Mar. 31, 2021	0
Temporary equity, value of shares outstanding at end of period at Mar. 31, 2021	$ 0
Shares outstanding at beginning of period (in shares) at Dec. 31, 2020		22,320,286
Stockholders' equity balance at beginning of period at Dec. 31, 2020	(52,481)	$ 22	$ 16,798	$ (69,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Initial public offering, net of underwriting discount and deferred offering costs (in shares)		20,700,000
Initial public offering, net of underwriting discount and deferred offering costs	477,826	$ 21	477,805
Accretion of redeemable convertible preferred stock to redemption value	(14)		(14)
Issuance of preferred stock on exercise of warrants	39,056		39,056
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)		100,196,780
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	111,753	$ 100	111,653
Issuance of common stock upon settlement of Share Appreciation Rights (in shares)		1,642,570
Issuance of common stock upon settlement of Share Appreciation Rights	2,847	$ 2	2,845
Issuance of common stock in connection with charitable donation (in shares)		172,918
Issuance of common stock in connection with charitable donation	5,125		5,125
Issuance of common stock on exercise of stock options (in shares)		1,965,824
Issuance of common stock on exercise of stock options	2,157	$ 2	2,155
Stock-based compensation	5,426		5,426
Net loss	(26,457)			(26,457)
Shares outstanding at end of period (in shares) at Mar. 31, 2021		146,998,378
Stockholders' equity balance at end of period at Mar. 31, 2021	$ 565,238	$ 147	660,849	(95,758)
Temporary equity, shares outstanding at beginning of period (in shares) at Dec. 31, 2020	58,962,749
Temporary equity, value of shares outstanding at beginning of period at Dec. 31, 2020	$ 111,737
Temporary equity, shares outstanding at end of period (in shares) at Sep. 30, 2021	0
Temporary equity, value of shares outstanding at end of period at Sep. 30, 2021	$ 0
Shares outstanding at beginning of period (in shares) at Dec. 31, 2020		22,320,286
Stockholders' equity balance at beginning of period at Dec. 31, 2020	(52,481)	$ 22	16,798	(69,301)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive loss	0
Net loss	(40,202)
Shares outstanding at end of period (in shares) at Sep. 30, 2021		150,855,395
Stockholders' equity balance at end of period at Sep. 30, 2021	$ 583,068	$ 151	692,420	(109,503)
Temporary equity, shares outstanding at beginning of period (in shares) at Mar. 31, 2021	0
Temporary equity, value of shares outstanding at beginning of period at Mar. 31, 2021	$ 0
Temporary equity, shares outstanding at end of period (in shares) at Jun. 30, 2021	0
Temporary equity, value of shares outstanding at end of period at Jun. 30, 2021	$ 0
Shares outstanding at beginning of period (in shares) at Mar. 31, 2021		146,998,378
Stockholders' equity balance at beginning of period at Mar. 31, 2021	565,238	$ 147	660,849	(95,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Reversal of deferred offering costs	1,145		1,145
Issuance of common stock on exercise of stock options (in shares)		698,453
Issuance of common stock on exercise of stock options	950	$ 1	949
Stock-based compensation	8,198		8,198
Net loss	(2,437)			(2,437)
Shares outstanding at end of period (in shares) at Jun. 30, 2021		147,696,831
Stockholders' equity balance at end of period at Jun. 30, 2021	$ 573,094	$ 148	671,141	(98,195)
Temporary equity, shares outstanding at end of period (in shares) at Sep. 30, 2021	0
Temporary equity, value of shares outstanding at end of period at Sep. 30, 2021	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with charitable donation (in shares)		172,918
Issuance of common stock in connection with charitable donation	7,982		7,982
Issuance of common stock on exercise of stock options (in shares)		2,984,858
Issuance of common stock on exercise of stock options	5,373	$ 3	5,370
Vesting of restricted stock units (in shares)		788
Stock-based compensation	7,927		7,927
Other comprehensive loss	0
Net loss	(11,308)			(11,308)
Shares outstanding at end of period (in shares) at Sep. 30, 2021		150,855,395
Stockholders' equity balance at end of period at Sep. 30, 2021	583,068	$ 151	692,420	(109,503)
Shares outstanding at beginning of period (in shares) at Dec. 31, 2021		157,700,189
Stockholders' equity balance at beginning of period at Dec. 31, 2021	701,750	$ 158	813,166	(111,574)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock on exercise of stock options (in shares)		1,851,334
Issuance of common stock on exercise of stock options	2,307	$ 2	2,305
Vesting of restricted stock units (in shares)		136,662
Stock-based compensation	12,457		12,457
Net loss	(11,509)			(11,509)
Shares outstanding at end of period (in shares) at Mar. 31, 2022		159,688,185
Stockholders' equity balance at end of period at Mar. 31, 2022	705,005	$ 160	827,928	(123,083)	0
Shares outstanding at beginning of period (in shares) at Dec. 31, 2021		157,700,189
Stockholders' equity balance at beginning of period at Dec. 31, 2021	$ 701,750	$ 158	813,166	(111,574)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock on exercise of stock options (in shares)	4,915,101
Other comprehensive loss	$ (420)
Net loss	(37,742)
Shares outstanding at end of period (in shares) at Sep. 30, 2022		163,484,846
Stockholders' equity balance at end of period at Sep. 30, 2022	711,001	$ 163	860,574	(149,316)	(420)
Shares outstanding at beginning of period (in shares) at Mar. 31, 2022		159,688,185
Stockholders' equity balance at beginning of period at Mar. 31, 2022	705,005	$ 160	827,928	(123,083)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under the employee stock purchase plan (in shares)		193,267
Issuance of common stock under the Employee Stock Purchase Plan	1,764		1,764
Issuance of common stock on exercise of stock options (in shares)		1,118,331
Issuance of common stock on exercise of stock options	2,323	$ 1	2,322
Vesting of restricted stock units (in shares)		199,738
Stock-based compensation	11,750		11,750
Other comprehensive loss	(251)				(251)
Net loss	(11,673)			(11,673)
Shares outstanding at end of period (in shares) at Jun. 30, 2022		161,199,521
Stockholders' equity balance at end of period at Jun. 30, 2022	708,918	$ 161	843,764	(134,756)	(251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with charitable donation (in shares)		172,918
Issuance of common stock in connection with charitable donation	1,406		1,406
Issuance of common stock on exercise of stock options (in shares)		1,945,436
Issuance of common stock on exercise of stock options	3,030	$ 2	3,028
Vesting of restricted stock units (in shares)		166,971
Stock-based compensation	12,376		12,376
Other comprehensive loss	(169)				(169)
Net loss	(14,560)			(14,560)
Shares outstanding at end of period (in shares) at Sep. 30, 2022		163,484,846
Stockholders' equity balance at end of period at Sep. 30, 2022	$ 711,001	$ 163	$ 860,574	$ (149,316)	$ (420)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities
Net loss	$ (37,742)	$ (40,202)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,285	800
Stock-based compensation	35,104	21,417
Stock-based compensation in connection with vesting of Stock Appreciation Rights	0	2,847
Charitable donation of Class A common stock	1,406	13,107
Bad debt expense	263	283
Change in fair value of warrants	0	18,930
Non-cash lease expense	1,706	0
Deferred income tax benefit	(1,421)	0
Non-cash impairment charges	2,806	0
Other non-cash loss, net	(560)	0
Changes in operating assets and liabilities:
Accounts receivable	(602)	4,966
Contract assets	(66)	(898)
Prepaid expenses and other current assets	(404)	(3,256)
Deferred contract costs	(537)	(594)
Accounts payable	(452)	(3,721)
Accrued expenses and other current liabilities	927	10,350
Operating lease liabilities	(1,893)	0
Unearned revenue	(558)	2,354
Other liabilities, noncurrent	136	(174)
Net cash provided by operating activities	2,398	26,209
Investing activities
Purchases of property and equipment	(454)	(324)
Capitalized internal-use software	(6,997)	(871)
Acquisitions, net of cash acquired	(49,241)	0
Purchases of investments	(114,006)	0
Sales and maturities of investments	11,388	0
Net cash used in investing activities	(159,310)	(1,195)
Financing activities
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts	0	485,541
Cash received for employee payroll tax withholdings	7,083	25,696
Cash paid for employee payroll tax withholdings	(7,012)	(18,691)
Proceeds from exercise of warrants	0	392
Payment of deferred finance costs	0	(135)
Payment of deferred offering costs	(423)	(4,118)
Proceeds from exercise of stock options and purchases under employee stock purchase plan	9,218	8,287
Net cash provided by financing activities	8,866	496,972
Net (decrease) increase in cash and cash equivalents	(148,046)	521,986
Cash and cash equivalents, beginning of period	514,445	75,756
Cash and cash equivalents, end of period	366,399	597,742
Supplemental disclosure of non-cash investing and financing activities
Accrued offering costs	0	339
Vesting of early exercised stock options	174	174
Accretion of redeemable convertible preferred stock to redemption value	0	14
Purchase of property and equipment on account	0	34
Capitalization of stock-based compensation for internal-use software	$ 1,856	$ 173

Business

Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business	Business Olo Inc. was formed on June 1, 2005 in Delaware and is headquartered in New York City. On January 14, 2020, our Board of Directors and stockholders approved our name change from Mobo Systems, Inc. to Olo Inc. Unless the context otherwise indicates or requires, references to “we,” “us,” “our,” and “the Company” shall refer to Olo Inc. We are an open SaaS platform for restaurants powering the industry’s digital transformation. Our platform powers restaurant brands’ on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants’ direct consumer relationships. We provide restaurants with a business-to-business-to-consumer, enterprise-grade, open SaaS platform to manage their complex digital businesses and enable fast and more personalized experiences for their guests. Our platform and application programming interfaces seamlessly integrate with a wide range of solutions, unifying disparate technologies across the restaurant ecosystem. Restaurant brands rely on us to increase their digital omni-channel sales, maximize profitability, establish and maintain direct guest relationships, and collect, protect, and leverage valuable customer data. Emerging Growth Company Status We currently qualify as an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act, until such time as those standards apply to private companies. We have elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As a result, our financial statements may not be comparable to financial statements of issuers that are required to comply with the effective dates for new or revised accounting standards based on public company effective dates. However, as of the last business day of our second fiscal quarter of 2022, the market value of our Class A common stock that was held by non-affiliates exceeded $700 million, and as a result, we will no longer qualify as an emerging growth company as of the end of the current fiscal year ending December 31, 2022, and we will be subject to certain requirements that apply to other public companies but did not previously apply to us due to our status as an emerging growth company, including the provisions of Section 404(b) of the Sarbanes-Oxley Act of 2002, which require that our independent registered public accounting firm provide an attestation report on the effectiveness of our internal control over financial reporting. In addition, we will no longer be able to take advantage of the extended transition period as of the end of the current fiscal year ending December 31, 2022, and we will be required to adopt new or revised accounting standards when they are applicable to public companies that are not emerging growth companies. Initial Public Offering On March 19, 2021, we completed our IPO in which we issued and sold 20,700,000 shares of our Class A common stock at the public offering price of $25.00 per share. We received net proceeds of approximately $485.5 million after deducting underwriting discounts and commissions. Upon completion of the IPO, $6.6 million of deferred offering costs, which consisted primarily of accounting, legal, and other fees related to our IPO, were reclassified into stockholders’ deficit as a reduction of the IPO proceeds.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. The December 31, 2021 condensed consolidated balance sheet was derived from the audited financial statements as of that date, but may not include all disclosures including certain footnotes required by U.S. GAAP on an annual reporting basis. These unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual financial statements and, in the opinion of management, reflect all adjustments, which include all normal recurring adjustments necessary to fairly state our financial position as of September 30, 2022, our results of operations and comprehensive loss for the three and nine months ended September 30, 2022 and 2021 and our cash flows for the nine months ended September 30, 2022 and 2021, respectively. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022 or for any other future annual or interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K filed with the SEC on February 25, 2022. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. We regularly assess these estimates, including but not limited to, stock-based compensation including the determination of the fair value of our stock-based awards, realization of deferred tax assets, estimated life of our long-lived assets, purchase price allocations for business combinations, valuation of the acquired intangibles purchased in a business combination, valuation of goodwill, estimated standalone selling price of our performance obligations, and estimated consideration for implementation services and transactional revenue in certain arrangements. We base these estimates on historical experience and on various other market-specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates and such differences could be material to our financial position and results of operations. Significant Accounting Policies Our significant accounting policies are outlined in Note 2, “Significant Accounting Policies” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2021. During the nine months ended September 30, 2022, there were no material changes to our critical accounting policies from those described in our Annual Report on Form 10-K for the year ended December 31, 2021, except as described below. Concentrations of Business and Credit Risk We are exposed to concentrations of credit risk primarily through our cash and short- and long-term investments held by financial institutions. We primarily deposit our cash with two financial institutions and the amount on deposit exceeds federally insured limits. We reduce our credit risk by placing our cash and investments with major financial institutions with high credit ratings. As of September 30, 2022 and December 31, 2021, no customer had a balance over 10% of our accounts receivable. For the three months ended September 30, 2022 and 2021, one customer accounted for 12% and 16% of our revenue, respectively. For the nine months ended September 30, 2022 and 2021, one customer accounted for 12% and 19% of our revenue, respectively. Investments Management determines the appropriate classification of investments at the time of purchase based upon management’s intent with regard to such investments. Our investments are classified as available-for-sale at the time of purchase, and we reevaluate such classification as of each balance sheet date. We consider all highly liquid investments with an original maturity of 90 days or less when purchased to be cash equivalents. Investments with remaining contractual maturities of one year or less from the balance sheet date, which are not considered cash equivalents, are classified as short-term investments, and those with remaining contractual maturities greater than one year from the balance sheet date are classified as long-term investments. All investments are recorded at their estimated fair value, and any unrealized gains and losses, net of taxes, are recorded in accumulated other comprehensive loss, which is reflected as a separate component of stockholders’ equity in the condensed consolidated balance sheets. Realized gains and losses on sales and maturities of investments are determined based on the specific identification method and are recognized in the condensed consolidated statements of operations. We perform periodic evaluations to determine whether any declines in the fair value of investments below cost are other-than-temporary. The evaluation consists of qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investments until a forecasted recovery occurs. The impairments are considered to be other-than-temporary if they are related to deterioration in credit risk or if it is likely that the underlying securities will be sold prior to a full recovery of their cost basis. Other-than-temporary fair value impairments, if any, are determined based on the specific identification method and are reported in other (expense) income, net in the condensed consolidated statements of operations. Accounts Receivable, Net Accounts receivable, net are stated at net realizable value and include unbilled receivables. Unbilled receivables arise primarily from transactional services provided in advance of billing. Accounts receivable are net of an allowance for credit losses, are not collateralized, and do not bear interest. Payment terms vary by contract type but are generally due within 30 days. The accounts receivable balance at September 30, 2022 and December 31, 2021 included unbilled receivables of $0.6 million and $4.1 million, respectively. We assess the collectability of outstanding accounts receivable on an ongoing basis and maintain an allowance for credit losses for accounts receivable deemed uncollectible. Upon adoption of Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, we analyzed our accounts receivable portfolio for significant risks, historical activity, and an estimate of future collectability to determine the amount that will ultimately be collected. This estimate is analyzed annually and adjusted as necessary or upon certain triggering events. Identified risks pertaining to our accounts receivable include the delinquency level, customer type, and current economic environment. Due to the short-term nature of such receivables, the estimate of the amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances and the financial condition of customers. The following summarizes our allowance for doubtful accounts activity (in thousands): September 30, 2022 2021 Beginning balance $ 657 $ 631 Bad debt expense 263 283 Writeoffs (308) (257) Ending balance $ 612 $ 657 Business Combinations We account for acquisitions using the acquisition method of accounting and determine whether a transaction constitutes a business and is treated as a business combination or if the transaction does not constitute a business and is treated as an asset acquisition. The acquisition method of accounting requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The results of businesses acquired in a business combination are included in our condensed consolidated financial statements from the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including estimates of future revenue and adjusted earnings before interest and taxes and discount rates. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ materially from estimates. Our estimates associated with the accounting for business combinations may change as additional information becomes available regarding the assets acquired and liabilities assumed. Any change in facts and circumstances that existed as of the acquisition date and impacts our estimates is recorded to goodwill if identified within the measurement period. Subsequent to the measurement period or our final determination of fair value of assets and liabilities, whichever is earlier, the adjustments will affect our earnings. Transaction related expenses incurred in a business combination are not included as a component of consideration transferred, but are accounted for as an expense in the period in which the costs are incurred. Goodwill and Intangible Assets Goodwill represents the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interest, if any, over the fair value of identifiable assets acquired and liabilities assumed in a business combination. We have no intangible assets, other than goodwill, with indefinite useful lives. Intangible assets other than goodwill are comprised of acquired developed technology, customer relationships, and trademarks. At initial recognition, intangible assets acquired in a business combination or asset acquisition are recognized at their fair value as of the date of acquisition. Following initial recognition, intangible assets are carried at acquisition date fair value less accumulated amortization and impairment losses, if any, and are amortized on a straight-line basis over the estimated useful life of the asset. We review goodwill for impairment annually on October 1st (beginning day of the fourth quarter) of each fiscal year or whenever events or changes in circumstances indicate that an impairment may exist. In the first nine months of 2022, there were no events or changes in circumstances that would have required an interim impairment test. In conducting our annual impairment test, we review qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If factors indicate that the fair value of the reporting unit is less than its carrying amount, we perform a quantitative assessment and the fair value of the reporting unit is determined by analyzing the expected present value of future cash flows. If the carrying value of the reporting unit continues to exceed its fair value, the fair value of the reporting unit’s goodwill is calculated and an impairment loss equal to the excess is recorded. We assess the impairment of intangible assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Leases Prior to the adoption of Accounting Standards Codification (“ASC”) 842, Leases, on January 1, 2022 We categorized leases at their inception as either operating or capital. In the ordinary course of business, we enter into non-cancelable operating leases for office space. We recognized lease costs on a straight-line basis and treated lease incentives as a reduction of rent expense over the term of the agreement. The difference between cash rent payments and rent expense was recorded as a deferred rent liability, with the amount expected to be amortized within the next twelve months classified as a current liability. We subleased a portion of our office space and recognize rental income on a straight-line basis as an offset to rent expense within general and administrative costs. The difference between cash rent payments received and rental income was recorded within prepaid expenses and other current assets. Subsequent to the adoption of ASC 842 on January 1, 2022 We determine if an arrangement is a lease or contains a lease at inception. Our lease agreements are generally for office facilities, and the determination of whether such agreements contain leases generally does not require significant estimates or judgments. Our leases may also contain non-lease components such as payments of maintenance, utilities, and taxes, which we have elected to account for separately, as these amounts are readily determinable. At the commencement date of a lease, we recognize a liability to make lease payments and an asset representing the right to use the underlying asset during the lease term. The lease liability is measured at the present value of the minimum rental payments discounted using our incremental borrowing rate (“IBR”) over the lease term (or, if readily determinable, the rate implicit in the lease). The right-of-use asset is measured at cost, which includes the initial measurement of the lease liability and initial direct costs incurred and excludes lease incentives. We subleased a portion of our office space and recognize rental income on a straight-line basis as an offset to other leases costs, net within general and administrative expenses. The lease term used to measure right-of-use lease assets and lease liabilities may include renewal options which are deemed reasonably certain to be exercised. Operating lease costs are recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred. Our leases do not contain any material residual value guarantees or material restrictive covenants. Recently Adopted Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASC 842”) , which requires lessees to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Additional disclosures are required to allow financial statement users to assess the amount, timing, and uncertainty of cash flows arising from leasing activities. A modified retrospective transition approach is required for leases existing at the time of adoption. We adopted and began applying the standard on January 1, 2022 using the modified retrospective approach and applied it to all existing leases as of the adoption date. We will continue to present prior period amounts under ASC 840, Leases . In addition, we elected the package of practical expedients permitted under the transition guidance within the new standard which does not require us to reassess whether contracts that existed or expired prior to the adoption date contained an embedded lease, reassess historical lease classification, or evaluate initial direct costs for leases that were in effect at the adoption date. We did not elect the hindsight practical expedient related to determining the lease term. As a result of implementing this guidance, we recognized $20.6 million in operating lease right-of-use assets as of January 1, 2022, and derecognized $2.4 million of previously recognized deferred rent. We also recorded $2.5 million in current operating lease liabilities and $18.1 million in operating lease liabilities, net of current portion in our condensed consolidated balance sheet as of January 1, 2022. The adoption of ASC 842 did not result in a cumulative-effect adjustment on retained earnings. See “Note 11—Leases” for additional details. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires an entity to utilize the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model results in more timely recognition of credit losses. This guidance also requires new disclosures for financial assets measured at amortized cost, loans, and available-for-sale debt securities. We adopted this standard as of January 1, 2022. The adoption did not have a material impact on our condensed consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires an acquirer to recognize and measure contract assets and contract liabilities in accordance with ASC Topic 606, Revenue from Contracts with Customers . Under prior guidance, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We early adopted ASU No 2021-08 as of January 1, 2022 on a

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The following table disaggregates revenue by type (in thousands): Three Months Ended September 30, 2022 Platform Professional Total Timing of revenue recognition Transferred over time $ 23,919 $ 909 $ 24,828 Transferred at a point in time 22,438 — 22,438 Total revenue $ 46,357 $ 909 $ 47,266 Three Months Ended September 30, 2021 Platform Professional Total Timing of revenue recognition Transferred over time $ 17,046 $ 1,306 $ 18,352 Transferred at a point in time 19,038 — 19,038 Total revenue $ 36,084 $ 1,306 $ 37,390 Nine Months Ended September 30, 2022 Platform Professional Total Timing of revenue recognition Transferred over time $ 67,710 $ 3,262 $ 70,972 Transferred at a point in time 64,651 — 64,651 Total revenue $ 132,361 $ 3,262 $ 135,623 Nine Months Ended September 30, 2021 Platform Professional Total Timing of revenue recognition Transferred over time $ 47,902 $ 3,876 $ 51,778 Transferred at a point in time 57,631 — 57,631 Total revenue $ 105,533 $ 3,876 $ 109,409 Contract Balances Contract Assets Professional services revenue is generally recognized ratably over the implementation period, beginning on the commencement date of each contract. Platform revenue is recognized as the services are delivered. Under ASC Topic 606, we record a contract asset when revenue recognized on a contract exceeds the billings. Our standard billing terms are monthly; however, the billings may not be consistent with the pattern of recognition, based on when services are performed. Contract assets were $1.0 million as of each of September 30, 2022 and December 31, 2021. Unearned Revenue Unearned revenue primarily consists of billings or payments received in advance of revenue recognition from subscription services and is recognized as revenue when transfer of control to customers has occurred. During the nine months ended September 30, 2022, we recognized $1.2 million of revenue related to contracts that were included in unearned revenue at December 31, 2021. During the nine months ended September 30, 2021, we recognized $0.4 million of revenue related to contracts that were included in unearned revenue at December 31, 2020. As of September 30, 2022, our remaining performance obligations were approximately $40.8 million, approximately 45% of which we expect to recognize as revenue over the next twelve months, and substantially all of the remaining revenue will be recognized thereafter over the next 24 to 48 months. These amounts only include contracts subject to a guaranteed fixed amount or the guaranteed minimum under variable contracts. Unrecognized revenues under contracts disclosed above do not include: (1) contracts with an original expected term of one year or less; (2) contracts for which variable consideration is determined based on the customer’s subsequent sale or usage; and (3) agreements for which our right to invoice corresponds with the value provided to the customer. Deferred Contract Costs The following table summarizes the activity of current and non-current deferred contract costs (in thousands): Nine Months Ended September 30, 2022 2021 Beginning balance $ 6,183 $ 5,176 Capitalization of deferred contract costs 3,084 2,607 Amortization of deferred contract costs (2,547) (2,013) Ending balance $ 6,720 $ 5,770

Fair Value Measurement

Fair Value Measurement	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement Fair value is the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 inputs: Based on unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 inputs: Based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 inputs: Based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities, and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The following tables present the costs, net unrealized losses, and fair value by major security type for our investments as of September 30, 2022 and December 31, 2021 (in thousands): As of September 30, 2022 Cost Net Unrealized Losses Fair Value Cash and cash equivalents Short-term investments Long-term investments Cash $ 224,315 $ — $ 224,315 $ 224,315 $ — $ — Level 1: Money market funds 140,977 — 140,977 140,977 — — Commercial paper 20,617 (73) 20,544 905 19,639 — Subtotal 161,594 (73) 161,521 141,882 19,639 — Level 2: Certificates of deposit 32,857 (124) 32,733 — 32,733 — U.S. Government and agency securities 27,392 (86) 27,306 — 27,306 — Corporate bonds 23,421 (137) 23,284 202 22,278 804 Subtotal 83,670 (347) 83,323 202 82,317 804 Level 3: — — — — — — Total $ 469,579 $ (420) $ 469,159 $ 366,399 $ 101,956 $ 804 As of December 31, 2021 Cost Net Unrealized Losses Fair Value Cash and cash equivalents Short-term investments Long-term investments Cash $ 219,344 $ — $ 219,344 $ 219,344 $ — $ — Level 1: Money market funds 295,101 — 295,101 295,101 — — Total $ 514,445 $ — $ 514,445 $ 514,445 $ — $ — Our assets measured at fair value on a nonrecurring basis include long-lived assets and finite-lived intangibles, which are considered to be Level 3 inputs. During the nine months ended September 30, 2022, we determined that the estimated fair value of a portion of our internal-use software was non-recoverable, and we recorded a non-cash impairment charge of $0.5 million, as more fully described in “Note 5—Property and Equipment.” In addition, during the three months ended September 30, 2022, we entered into a sublease of our corporate headquarters, and in connection with this, we recorded a non-cash impairment charge of $2.3 million related to our right-of-use asset and furniture and fixtures within the leased space. See “Note 11—Leases” for additional information on the new sublease agreement. Accounts receivable, accounts payable and accrued expenses are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment consisted of the following (in thousands): Estimated Useful Life As of September 30, 2022 As of December 31, 2021 Computer and office equipment 3 - 5 $ 2,186 $ 1,800 Capitalized internal-use software 3 11,770 3,392 Furniture and fixtures 10 132 386 Leasehold improvements Shorter of estimated useful life or remaining term of lease 364 374 Total property and equipment 14,452 5,952 Less: accumulated depreciation and amortization of internal-use software (3,912) (2,648) Total property and equipment, net $ 10,540 $ 3,304 Depreciation and amortization expense from property and equipment was approximately $0.7 million and $0.3 million for the three months ended September 30, 2022 and 2021, respectively. Depreciation and amortization expense from property and equipment was approximately $1.5 million and $0.8 million for the nine months ended September 30, 2022 and 2021, respectively. We recorded a non-cash impairment charge of $0.5 million for the nine months ended September 30, 2022 related to a portion of our internal-use software that was abandoned. This amount was recorded in research and development expenses within the condensed consolidated statement of operations. In addition, we recorded a non-cash impairment charge of $0.1 million

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions Omnivore Acquisition On February 20, 2022, we signed a definitive agreement to acquire Omnivore Technologies, Inc. (“Omnivore”), a restaurant technology provider that connects restaurants’ Point of Sale systems with technologies that improve efficiency and increase profitability. We closed the acquisition on March 4, 2022 for total consideration of approximately $49.3 million in cash, net of cash acquired and a post-closing working capital adjustment. The operating results of Omnivore have been included in our condensed consolidated statement of operations since the acquisition date. Actual results of operations from the date of acquisition through September 30, 2022 and supplemental pro forma revenue and results of operations have not been presented because the effects were not material to the condensed consolidated financial statements. Purchase Price Allocation The acquisition was accounted for under the acquisition method in accordance with ASC 805, Business Combinations . We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition. The following table summarizes the preliminary allocation of the purchase price to the fair value of the assets acquired and liabilities assumed of Omnivore as of March 4, 2022 (in thousands): Initial Fair Value Estimate Accounts receivable $ 451 Other current assets 148 Operating lease right-of-use asset 236 Property and equipment 24 Other assets, noncurrent 9 Customer relationships 1,290 Developed technology 4,410 Trademark 150 Goodwill 44,678 Accounts payable (198) Accrued expenses and other current liabilities (101) Unearned revenue (83) Operating lease liability, current (81) Operating lease liability, noncurrent (177) Deferred tax liability, net (1,421) Total purchase price, net of cash acquired and post-closing working capital adjustment $ 49,335 Customer relationships were measured at fair value using the multiple-period excess earnings method under the income approach. Significant inputs used to measure the fair value include an estimate of projected revenue and costs associated with existing customers, and a discount rate of 11.0%. Developed technology was measured at fair value using the relief-from-royalty method of the income approach. Significant inputs used to measure the fair value include an estimate of projected revenue from existing technology, a pre-tax royalty rate of 20.0% and a discount rate of 11.0%. Trademark was measured at fair value using the relief-from-royalty method under the income approach. Significant inputs used to measure the fair value include an estimate of projected revenue from the trademark, a pre-tax royalty rate of 1.0% and a discount rate of 11.0%. The preliminary purchase price allocation resulted in the recognition of $44.7 million of goodwill. Goodwill represents the future economic benefits expected to arise from other intangible assets acquired that do not qualify for separate recognition, including an experienced workforce that will help accelerate product development and go to market strategy, as well as expected future synergies generated by integrating Omnivore’s products with those in our existing platform. Accordingly, Omnivore will be reported along with our historical solutions under the same operating segment. None of the goodwill is expected to be deductible for tax purposes. We recorded $1.2 million in transaction related expenses, primarily related to transaction related compensation, advisory, legal, valuation, and other professional fees, for the nine months ended September 30, 2022. The transaction related expenses are recorded within the condensed consolidated statements of operations as follows (in thousands): Operating expenses: Sales and marketing $ 79 General and administrative 1,155 Total transaction costs $ 1,234 We expect to finalize the purchase price allocation after management has further analyzed and assessed a number of the factors used in establishing the fair values of assets acquired and liabilities assumed as of the acquisition date, including, but not limited to, the working capital acquired. Wisely Acquisition On October 21, 2021, we signed a definitive agreement to acquire all of the outstanding shares of Wisely Inc. (“Wisely”), a customer intelligence and engagement platform for restaurants. We believe Wisely’s Guest Engagement and Front-of-House solutions complement our existing solution suite and enhance our value to our customers. We closed the acquisition on November 4, 2021 for total consideration of approximately $177.8 million, consisting of $75.2 million in cash (net of cash acquired), $96.6 million of Class A common stock, and $5.9 million of substituted stock options granted in connection with the acquisition. The fair values of the Class A common stock and substituted stock options were based on a price per Class A common share of $27.93, which is equal to the closing price of our Class A common stock on the date of the transaction. As a result of the equity consideration component, we issued approximately 3.5 million shares of our Class A common stock and granted approximately 0.2 million fully vested stock options at the acquisition date. The fair value of the substituted options granted was based upon the estimated value of vested stock options held by Wisely employees immediately prior to the acquisition. We recorded $0.2 million in transaction related expenses, primarily related to legal and insurance fees, for the nine months ended September 30, 2022 in general and administrative expenses within the condensed consolidated statement of operations.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table summarizes the changes in the carrying amount of goodwill (in thousands): Balance at December 31, 2021 $ 162,956 Adjustment to Wisely acquisition (94) Acquisition of Omnivore 44,678 Balance at September 30, 2022 $ 207,540 The gross book value and accumulated amortization of intangible assets, net, as of September 30, 2022 were as follows (in thousands): Weighted-average Remaining Useful Life (in years) Gross Carrying Value Accumulated Amortization Net Carrying Value Developed technology 5.2 $ 14,595 $ (1,985) $ 12,610 Customer relationships 7.2 10,921 (1,197) 9,724 Trademark 2.1 486 (132) 354 Balance at September 30, 2022 $ 26,002 $ (3,314) $ 22,688 Amortization expense associated with intangible assets was $1.0 million and $2.8 million for the three and nine months ended September 30, 2022, respectively. As of September 30, 2022, estimated amortization related to the identifiable acquisition-related intangible assets expected to be recognized in future periods was as follows (in thousands): 2022 (remaining) $ 950 2023 3,967 2024 3,949 2025 3,813 2026 3,804 Thereafter 6,205 Total $ 22,688 No goodwill or intangible asset impairment losses were recognized during the nine months ended September 30, 2022. See “Note 6—Acquisitions” for additional information on the acquisitions of Omnivore and Wisely.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): As of September 30, 2022 As of December 31, 2021 Prepaid software licensing fees $ 2,466 $ 1,888 Prepaid insurance 504 1,298 Other 3,674 2,532 Total prepaid expenses and other current assets $ 6,644 $ 5,718

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accrued Expenses and Other Liabilities	Accrued Expenses and Other Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of September 30, 2022 As of December 31, 2021 Accrued delivery service partner fees $ 35,111 $ 35,441 Accrued compensation and benefits 6,036 4,189 Professional and consulting fees 709 1,806 Accrued taxes 1,261 1,538 Other 3,426 2,421 Total accrued expenses and other current liabilities $ 46,543 $ 45,395

Line of Credit

Line of Credit	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Line of Credit	Line of Credit On June 10, 2022, we entered into the Second Amended and Restated Loan and Security Agreement with Pacific Western Bank related to a revolving credit and term loan facility (the “Second Amended and Restated LSA”). The Second Amended and Restated LSA amended and restated the Amended and Restated Loan and Security Agreement, dated February 11, 2020, as amended (the “Prior LSA”) to, among other things, increase our available aggregate borrowing limit to $70.0 million and to provide the ability to request Pacific Western Bank to enter into commitments to increase the credit extensions available to us under the Second Amended and Restated LSA to up to $125.0 million (the “Accordion Facility”). Borrowings under the Second Amended and Restated LSA accrue interest at a variable annual rate equal to (i) in the case of Formula Advances (as defined in the Second Amended and Restated LSA), the greater of the variable rate of interest, per annum, most recently announced by Pacific Western Bank (the “Prime Rate”) or 3.25% or (ii) in the case of Term Loans (as defined in the Second Amended and Restated LSA), the greater of the Prime Rate plus 0.25% or 3.50%. The Second Amended and Restated LSA provides for a success fee payable upon an acquisition of Olo or termination of the Second Amended and Restated LSA (a “Success Fee Trigger”), in an amount equal to: (i) $800,000, if the Success Fee Trigger occurs prior to June 10, 2023; (ii) $600,000, if the Success Fee Trigger occurs on or after June 10, 2023 and prior to June 10, 2024; (iii) $400,000, if the Success Fee Trigger occurs on or after June 10, 2024 and prior to June 10, 2025; (iv) $200,000, if the Success Fee Trigger occurs on or after June 10, 2025 and prior to June 10, 2026; and (v) $0, if the Success Fee Trigger occurs on or after June 10, 2026. We are also required to pay a fee of 1.0% of the difference between (i) the highest outstanding principal balance during the term of the Second Amended and Restated LSA and (ii) $3.5 million if a Liquidity Event (as defined in the Second Amended and Restated LSA) occurs during the term and or within 24 months after the termination of the Second Amended and Restated LSA. Our obligations under the Second Amended and Restated LSA are secured by substantially all of our assets, including certain securities owned by us in any subsidiary. The Second Amended and Restated LSA includes a financial covenant requiring compliance with certain minimum revenue amounts. In addition, the Second Amended and Restated LSA contains representations and warranties generally consistent with the Prior LSA, as well as certain non-financial covenants, including, but not limited to, limitations on our ability to incur additional indebtedness or liens, pay dividends, or make certain investments. We were in compliance with these covenants as of September 30, 2022. The Second Amended and Restated LSA also contains events of default that include, among other things, non-payment defaults, covenant defaults, insolvency defaults, cross-defaults to other indebtedness and material obligations, judgment defaults, inaccuracy of representations and warranties, and a material adverse change. Any default that is not cured or waived could result in Pacific Western Bank exercising its rights and remedies under the Second Amended and Restated LSA, including, but not limited to, the acceleration of the obligations under the Second Amended and Restated LSA and related documentation, and would permit Pacific Western Bank to exercise remedies with respect to all of the collateral that secured such obligations. Pacific Western Bank has the right to terminate its obligation to make further advances to us immediately and without notice upon the occurrence and during the continuance of an event of default. Upon our request, Pacific Western Bank will provide us a payoff letter providing for, among other things, repayment of our obligations then outstanding, including the success fee, and for termination of Pacific Western Bank’s obligations to make additional credit extensions and termination of the liens under the Second Amended and Restated LSA. As of September 30, 2022, we had $43.6 million of commitments available under the Second Amended and Restated LSA, after consideration of $25.0 million in our letter of credit to DoorDash and $1.4 million in our letter of credit on the lease of our headquarters. As of September 30, 2022, we had no outstanding borrowings under the line of credit, and no amounts have been drawn against any of our letters of credit. Interest expense related to the Second Amended and Restated LSA was immaterial for the nine months ended September 30, 2022. No interest expense was recognized related to the Prior LSA for the nine months ended September 30, 2021.

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases We have a non-cancelable operating lease for our corporate headquarters in New York City (“Headquarters Lease”), which expires in May 2030, and a non-cancelable operating lease for our former office (“Former Headquarters”), which expires in September 2023. As a result of the acquisition of Omnivore, we have a non-cancelable operating lease in Clearwater, Florida (“Omnivore Lease”), which expires in January 2025. Our lease terms under the Omnivore Lease include periods under options to extend or terminate the lease. Currently, there are no operating leases where we believe it is reasonably certain that we will exercise any option to extend the initial term. In August 2022, we entered into a new sublease agreement for the remaining term of the Headquarters Lease. In accordance with ASC Topic 360, we evaluated the associated assets for impairment, which included the right-of-use asset and furniture and fixtures for the office space. We compared the expected future undiscounted cash flows attributable to the associated assets to the carrying value and determined that they were impaired. Based on this evaluation, we determined that a portion of the right-of-use asset was no longer recoverable and recorded a right-of-use asset impairment charge of $2.2 million. We also determined that furniture and fixtures related to the space were no longer recoverable, and recorded an asset impairment charge for the carrying value of the assets of $0.1 million. We also recorded broker commission fees of $0.9 million in connection with the subleasing of our headquarters. These impairment charges and commission expenses were recorded in general and administrative expenses in the condensed consolidated statement of operations. We also sublease a portion of our Former Headquarters, which we ceased using in connection with the signing of the Headquarters Lease. The sublease of our Former Headquarters expires in March 2023. As disclosed in “Note 2—Significant Accounting Policies,” we adopted ASC 842 on January 1, 2022. We have elected the “package of practical expedients,” which permits us not to reassess under ASC 842 our prior conclusions on expired or existing leases about lease identification, lease classification, and initial direct costs. Payments of maintenance, utilities, and taxes are expensed as incurred and excluded from right-of-use assets and lease liabilities, and were immaterial for the three and nine months ended September 30, 2022. Furthermore, we elected to not capitalize leases with a term of 12 months or less and recognize the lease expense for such leases on a straight-line basis over the lease term. The IBR is the rate of interest that we would have to pay to borrow on a collateralized basis over a similar term and amount equal to the lease payments in a similar economic environment. We determined our IBR by obtaining interest rates from various external financing sources and made certain adjustments to reflect the terms of the lease and type of the asset leased. The elements of lease expense were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2022 Operating lease costs $ 843 $ 2,513 Other lease income (87) (261) Total lease costs $ 756 $ 2,252 Rent expense, excluding sublease income, under ASC 840, Leases , was $0.8 million and $2.5 million for the three and nine months ended September 30, 2021, respectively. Rental income was $0.1 million and $0.3 million for the three and nine months ended September 30, 2021, respectively. Cash paid for amounts included in the initial measurement of lease liabilities were $2.7 million for the nine months ended September 30, 2022. As of September 30, 2022, the total remaining operating lease payments included in the measurement of lease liabilities were as follows (in thousands): 2022 (remaining) $ 907 2023 3,444 2024 2,877 2025 2,893 2026 2,960 Thereafter 10,114 Total future minimum lease payments 23,195 Less: imputed interest (4,201) Total $ 18,994 The weighted average remaining lease term and discount rate for the operating leases were as follows: As of September 30, Weighted average remaining lease term (years) 7.35 Weighted average discount rate 5.40% As of December 31, 2021, our future minimum payments under non-cancelable leases for operating facilities as determined prior to the adoption of ASC 842 were as follows (in thousands): 2022 $ 3,559 2023 3,352 2024 2,780 2025 2,885 2026 2,960 Thereafter 10,113 Total $ 25,649

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Changes in Capital Structure On March 5, 2021, our Board of Directors and stockholders approved an amended and restated certificate of incorporation effecting a 17-for-1 forward stock split of our issued and outstanding shares of common stock and Series A, A-1, B, C, D, and E preferred stock. Additionally, all outstanding equity instruments, including our time-based stock options, performance-based SARs, and preferred stock warrants, were adjusted to reflect the 17-for-1 forward stock split. The stock split was effected on March 5, 2021. The par value of the Class B common stock and redeemable convertible preferred stock was not adjusted as a result of the stock split. All issued and outstanding Class B common stock, redeemable convertible preferred stock, warrants to purchase shares of redeemable convertible preferred stock, and stock options, as well as the per share amounts, included in the accompanying financial statements have been adjusted to reflect this stock split for all periods presented. On March 5, 2021, our Board of Directors and stockholders approved and we implemented a dual class common stock structure where all existing shares of common stock converted to Class B common stock and we authorized a new class of common stock, Class A common stock. The authorized share capital for Class A common stock is 1,700,000,000 and the authorized share capital for Class B common stock is 185,000,000. The Class A common stock is entitled to one vote per share and the Class B common stock is entitled to ten votes per share. The Class A and Class B common stock have the same rights and privileges and rank equally, share ratably, and are identical in all respects and for all matters except for voting, conversion, and transfer rights. The Class B common stock converts to Class A common stock at any time at the option of the holder. References in the accompanying financial statements have been adjusted to reflect the dual class common stock structure and the changes in the number of authorized shares of common stock. We also authorized a total of 20,000,000 shares of undesignated preferred stock, par value $0.001 per share. Effective March 5, 2021, 124,012,926 outstanding shares of common stock were converted into an equivalent number of shares of our Class B common stock. Class A common stock and Class B common stock reserved for future issuance consisted of the following: As of September 30, As of December 31, Shares available for grant under employee stock purchase plan 5,145,300 3,760,115 Shares available for grant under stock option plan 22,597,825 18,994,572 Restricted stock units 4,710,098 1,082,980 Options issued and outstanding under stock option plan 31,960,236 36,716,816 Total common stock reserved for future issuance 64,413,459 60,554,483 Repurchases of Common Stock On September 7, 2022, our Board of Directors authorized a program to repurchase up to $100 million of our Class A common stock (the “Stock Buyback Program”). Under the Stock Buyback Program, shares of common stock may be repurchased from time to time on a discretionary basis through open market repurchases, privately negotiated transactions, block purchases, or other means, and will be structured to occur in compliance with applicable securities laws. The timing and actual number of shares repurchased, if any, will be determined by a committee established by the Board of Directors and depend on a variety of factors, including the Class A common stock price, trading volume, market conditions, our cash flow and liquidity profile, the capital needs of the business, and other considerations. We expect to fund repurchases with existing cash on hand. The Stock Buyback Program has no expiration date and may be modified, suspended, or terminated at any time by the Board of Directors at its discretion. As of September 30, 2022, we have not repurchased any shares under the Stock Buyback Program. Charitable Contributions In March 2021, our Board of Directors approved the issuance of 1,729,189 shares of our Class A common stock to an independent donor-advised fund sponsor, Tides Foundation, in conjunction with our Olo for Good initiative. We donated 172,918 shares of our Class A common stock to the Olo for Good Fund at Tides Foundation and recognized $1.4 million as a non-cash general and administrative expense in our condensed consolidated statement of operations for the three and nine months ended September 30, 2022. We donated 172,918 and 345,836 shares of our Class A common stock to the Olo for Good Fund at Tides Foundation and recognized $8.0 million and $13.1 million as a non-cash general and administrative expense in our condensed consolidated statement of operations for the three and nine months ended September 30, 2021, respectively. Through September 30, 2022, we have donated a total of 518,754 shares of our Class A common stock. We expect to donate 1/10th of the total remaining approved shares into the fund annually.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plans On March 5, 2021, our Board of Directors adopted our 2021 Equity Incentive Plan (“2021 Plan”). Prior to that date, we had established our 2015 Equity Incentive Plan (“2015 Plan”) and 2005 Equity Incentive Plan (“2005 Plan” and collectively with the 2021 Plan and 2015 Plan, the “Plans”). The 2021 Plan serves as the successor to the 2015 Plan and 2005 Plan and provides for the issuance of incentive and nonqualified stock options, SARs, restricted stock, and restricted stock units (“RSUs”), to employees, directors, consultants, and advisors. Stock options under the Plans may be granted with contractual terms of up to ten years (or five years if granted to a greater than 10.0% stockholder) and at prices no less than 100.0% of the estimated fair value of the shares on the date of grant as determined by our Board of Directors; provided, however, that the exercise price of an incentive stock option and nonqualified stock option granted to a greater than 10.0% stockholder shall not be less than 110.0% of the estimated fair value of the shares on the date of grant. Awards granted under the Plans generally vest over four years. Certain stock options have an early exercise feature. Shares purchased pursuant to the early exercise of stock options are subject to repurchase until those shares vest; therefore, cash received in exchange for unvested shares exercised is recorded as a liability on the accompanying condensed balance sheets, and is reclassified to Class B common stock and additional paid-in capital as the shares vest. There were 56,508 and 120,088 early exercised shares outstanding as of September 30, 2022 and December 31, 2021, respectively. As of September 30, 2022, there was a liability in the amount of $0.2 million recorded in accrued expenses and other current liabilities in our balance sheet because vesting is within the next 12 months. On March 13, 2021, our Board of Directors adopted a non-employee director compensation policy that became effective upon our IPO. The policy provides for annual cash retainers for non-employee directors and an additional cash retainer for those non-employee directors that serve as chairpersons or members of our audit, compensation, nominating and corporate governance, and other committees. Additionally, directors will have the option to receive their annual retainer amounts in cash or equity. Each new non-employee director appointed to the Board of Directors after the IPO date will be granted an initial RSU award with a value of $0.3 million subject to vesting over a three-year period. As of September 30, 2022 and December 31, 2021 the maximum number of shares authorized for issuance to participants under the Plans was 29,445,392 and 20,615,612, respectively. As of September 30, 2022 and December 31, 2021, the number of shares available for issuance to participants under the Plans was 22,597,825 and 18,994,572, respectively. During the nine months ended September 30, 2022 and 2021, no SARs were granted to employees. The SARs outstanding as of the time of the IPO were equity-classified and were measured at the grant date fair value. The SARs were vested and settled upon completion of the IPO and 1,642,570 shares of Class B common stock were issued in connection with this event. Compensation expense of $2.8 million was recognized for the nine months ended September 30, 2021. Restricted Stock Units The following summarizes the activity for the unvested RSUs during the nine months ended September 30, 2022: Shares Weighted- Unvested at December 31, 2021 1,082,980 $ 27.70 Granted 4,699,191 15.48 Vested (503,371) 20.40 Forfeited and canceled (568,702) 19.80 Unvested at September 30, 2022 4,710,098 $ 17.24 The total fair value of RSUs vested during the nine months ended September 30, 2022 was $5.1 million. Future stock-based compensation for unvested RSUs awarded as of September 30, 2022 was approximately $73.6 million and is expected to be recognized over a weighted-average period of 3.26 years. Stock Options The following summarizes our stock option activity for the nine months ended September 30, 2022 (in thousands, except share and per share amounts): Number of Weighted- Weighted- Aggregate As of December 31, 2021 36,716,816 $ 3.55 5.76 $ 633,730 Granted 1,100,118 14.72 Exercised (4,915,101) 1.56 Forfeited (941,597) 6.77 Vested and expected to vest as of September 30, 2022 31,960,236 $ 4.15 5.32 $ 144,435 Exercisable as of September 30, 2022 24,706,582 $ 2.73 4.47 $ 134,287 The following table summarizes the weighted-average grant date fair value of options granted, intrinsic value of options exercised, and fair value of options vested for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Weighted-average grant date fair value of options granted $ 4.45 N/A $ 4.87 $ 10.70 Intrinsic value of options exercised $ 18,074 $ 97,370 $ 59,212 $ 169,450 Total fair value of options vested $ 6,027 $ 10,709 $ 20,604 $ 29,355 Future stock-based compensation for unvested employee options granted and outstanding as of September 30, 2022 was $49.7 million and is expected to be recognized over a weighted-average period of 2.07 years. Valuation Assumptions We estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted-average assumptions: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Expected term (in years) 6.00 N/A 5.24 - 6.00 5.48 - 6.07 Volatility 36% N/A 32% - 36% 52% - 65% Risk-free interest rate 2.87% N/A 1.62% - 2.87% 0.50% - 1.06% Dividend yield 0% N/A 0% 0% Fair value of underlying common stock $11.07 N/A $11.07 - $15.75 $16.78 - $30.02 We elected to use the midpoint practical expedient to calculate the expected term. 2021 Employee Stock Purchase Plan On March 5, 2021, our Board of Directors and stockholders adopted our employee stock purchase plan (“ESPP”). The ESPP became effective immediately prior to the IPO. The ESPP authorized the issuance of 3,900,000 shares of our Class A common stock pursuant to purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our Class A common stock reserved for issuance will automatically increase on January 1 of each calendar year, commencing on January 1, 2022 through January 1, 2031, by the lesser of (1) 1.0% of the total number of shares of our Class A common stock outstanding on December 31 of the preceding calendar year, or (2) 11,700,000 Class A common shares; provided, that prior to the date of any such increase, our Board of Directors may determine that such increase will be less than the amount set forth in clauses (1) and (2). Employees may contribute, normally through payroll deductions, up to 15% of their earnings for the purchase of our Class A common stock under the ESPP. Our Class A common stock will be purchased for the accounts of employees participating in the ESPP at a price per Class A common share equal to the lower of (a) 85% of the fair market value of our Class A common stock on the first trading date of an offering, or (b) 85% of the fair market value of our Class A common stock on the date of purchase. The current offering period began in June 2022 and ends in December 2022. For the nine months ended September 30, 2022, we recorded approximately $1.2 million of compensation expense associated with our ESPP. Stock-Based Compensation Expense The classification of stock-based compensation expense, which includes expense for stock options, RSUs, SARs, and ESPP charges, by line item within the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Cost of revenue - platform $ 1,367 $ 762 $ 4,269 $ 1,942 Cost of revenue - professional services and other 167 116 565 362 Research and development 3,571 2,570 10,382 8,522 General and administrative 5,442 3,907 15,567 12,002 Sales and marketing 1,372 512 4,321 1,436 Total stock-based compensation expense $ 11,919 $ 7,867 $ 35,104 $ 24,264

Warrants

Warrants	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Warrants	Warrants

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We had an effective tax rate benefit of 2.61% and expense of (0.27)% for the nine months ended September 30, 2022 and 2021, respectively. The effective tax rate benefit for the nine months ended September 30, 2022 is driven primarily by the release of a portion of our valuation allowance for deferred tax assets following the recording of a deferred income tax liability as part of our accounting for the acquisition of Omnivore and adjustments to the full valuation allowance on our deferred tax assets, partially offset by state taxes. We maintain a full valuation allowance on our net federal and state deferred tax assets as we have concluded that it is more likely than not that the deferred tax assets will not be realized. We evaluated the available evidence supporting the realization of our deferred tax assets, including the amount and timing of future taxable income, and have determined that it is more likely than not that our net deferred tax assets will not be realized. Due to uncertainties surrounding the realization of the deferred tax assets, we maintain a full valuation allowance against substantially all of our net deferred tax assets. When we determine that we will be able to realize some portion or all of our deferred tax assets, an adjustment to our valuation allowance on our deferred tax assets would have the effect of increasing net income in the period such determination is made. We applied ASC 740, Income Taxes

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contingencies Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. If we determine that a loss is reasonably possible, and the loss or range of loss can be estimated, we will disclose the possible loss in the notes to our financial statements. Accounting for contingencies requires us to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Legal costs incurred in connection with loss contingencies are expensed as incurred. On September 26, 2022, a putative securities class action lawsuit was filed in the United States District Court for the Southern District of New York against us and certain executive officers, captioned Pompano Beach Police and Firefighters Retirement System v. Olo Inc., et. al. (Case 1:22-cv-08228). The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and alleges that Olo made materially false and misleading statements regarding the number of active locations. The lawsuit seeks unspecified damages, interest, costs and attorneys’ fees, and other unspecified relief that the Court deems appropriate. We believe the case is without merit and are vigorously defending this matter. We are unable to predict the outcome, or the possible loss or range of loss, if any, related to this matter.

Net Loss per Share Attributable

Net Loss per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Loss per Share Attributable to Common Stockholders	Net Loss per Share Attributable to Common Stockholders A reconciliation of net loss available to common stockholders and the number of shares in the calculation of basic net loss per share is as follows (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss $ (14,560) $ (11,308) $ (37,742) $ (40,202) Less: accretion of redeemable convertible preferred stock to redemption value — — — (14) Net loss attributable to Class A and Class B common stockholders—basic and diluted $ (14,560) $ (11,308) $ (37,742) $ (40,216) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Denominator: Weighted-average Class A and Class B common shares outstanding—basic and diluted 162,364,654 148,452,987 160,667,412 113,451,378 Net loss per share attributable to Class A and Class B common stockholders––basic and diluted $ (0.09) $ (0.08) $ (0.23) $ (0.35) The following participating securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Outstanding stock options 31,960,236 39,815,982 31,960,236 39,815,982 Outstanding restricted stock units 4,710,098 155,422 4,710,098 155,422 Outstanding shares estimated to be purchased under ESPP 125,128 143,815 125,128 143,815 Total 36,795,462 40,115,219 36,795,462 40,115,219

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and accompanying notes were prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and in accordance with the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. The December 31, 2021 condensed consolidated balance sheet was derived from the audited financial statements as of that date, but may not include all disclosures including certain footnotes required by U.S. GAAP on an annual reporting basis. These unaudited condensed consolidated financial statements have been prepared on a basis consistent with our annual financial statements and, in the opinion of management, reflect all adjustments, which include all normal recurring adjustments necessary to fairly state our financial position as of September 30, 2022, our results of operations and comprehensive loss for the three and nine months ended September 30, 2022 and 2021 and our cash flows for the nine months ended September 30, 2022 and 2021, respectively. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022 or for any other future annual or interim period. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with the consolidated financial statements and related notes included in our Annual Report on Form 10-K filed with the SEC on February 25, 2022. All intercompany balances and transactions have been eliminated in consolidation. Certain prior period amounts have been reclassified to conform to the current period presentation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.
Concentrations of Business	Concentrations of Business and Credit Risk We are exposed to concentrations of credit risk primarily through our cash and short- and long-term investments held by financial institutions. We primarily deposit our cash with two financial institutions and the amount on deposit exceeds federally insured limits. We reduce our credit risk by placing our cash and investments with major financial institutions with high credit ratings. As of September 30, 2022 and December 31, 2021, no customer had a balance over 10% of our accounts
Credit Risks	Concentrations of Business and Credit Risk We are exposed to concentrations of credit risk primarily through our cash and short- and long-term investments held by financial institutions. We primarily deposit our cash with two financial institutions and the amount on deposit exceeds federally insured limits. We reduce our credit risk by placing our cash and investments with major financial institutions with high credit ratings. As of September 30, 2022 and December 31, 2021, no customer had a balance over 10% of our accounts
Investments	Investments Management determines the appropriate classification of investments at the time of purchase based upon management’s intent with regard to such investments. Our investments are classified as available-for-sale at the time of purchase, and we reevaluate such classification as of each balance sheet date. We consider all highly liquid investments with an original maturity of 90 days or less when purchased to be cash equivalents. Investments with remaining contractual maturities of one year or less from the balance sheet date, which are not considered cash equivalents, are classified as short-term investments, and those with remaining contractual maturities greater than one year from the balance sheet date are classified as long-term investments. All investments are recorded at their estimated fair value, and any unrealized gains and losses, net of taxes, are recorded in accumulated other comprehensive loss, which is reflected as a separate component of stockholders’ equity in the condensed consolidated balance sheets. Realized gains and losses on sales and maturities of investments are determined based on the specific identification method and are recognized in the condensed consolidated statements of operations. We perform periodic evaluations to determine whether any declines in the fair value of investments below cost are other-than-temporary. The evaluation consists of qualitative and quantitative factors regarding the severity and duration of the unrealized loss, as well as our ability and intent to hold the investments until a forecasted recovery occurs. The impairments are considered to be other-than-temporary if they are related to deterioration in credit risk or if it is likely that the underlying securities will be sold prior to a full recovery of their cost basis. Other-than-temporary fair value impairments, if any, are determined based on the specific identification method and are reported in other (expense) income, net in the condensed consolidated statements of operations.
Accounts Receivable, Net	Accounts Receivable, Net Accounts receivable, net are stated at net realizable value and include unbilled receivables. Unbilled receivables arise primarily from transactional services provided in advance of billing. Accounts receivable are net of an allowance for credit losses, are not collateralized, and do not bear interest. Payment terms vary by contract type but are generally due within 30 days. The accounts receivable balance at September 30, 2022 and December 31, 2021 included unbilled receivables of $0.6 million and $4.1 million, respectively. We assess the collectability of outstanding accounts receivable on an ongoing basis and maintain an allowance for credit losses for accounts receivable deemed uncollectible. Upon adoption of Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,
Business Combinations	Business Combinations We account for acquisitions using the acquisition method of accounting and determine whether a transaction constitutes a business and is treated as a business combination or if the transaction does not constitute a business and is treated as an asset acquisition. The acquisition method of accounting requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The results of businesses acquired in a business combination are included in our condensed consolidated financial statements from the date of acquisition. Determining the fair value of assets acquired and liabilities assumed requires management to use significant judgment and estimates, including estimates of future revenue and adjusted earnings before interest and taxes and discount rates. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ materially from estimates. Our estimates associated with the accounting for business combinations may change as additional information becomes available regarding the assets acquired and liabilities assumed. Any change in facts and circumstances that existed as of the acquisition date and impacts our estimates is recorded to goodwill if identified within the measurement period. Subsequent to the measurement period or our final determination of fair value of assets and liabilities, whichever is earlier, the adjustments will affect our earnings. Transaction related expenses incurred in a business combination are not included as a component of consideration transferred, but are accounted for as an expense in the period in which the costs are incurred.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interest, if any, over the fair value of identifiable assets acquired and liabilities assumed in a business combination. We have no intangible assets, other than goodwill, with indefinite useful lives. Intangible assets other than goodwill are comprised of acquired developed technology, customer relationships, and trademarks. At initial recognition, intangible assets acquired in a business combination or asset acquisition are recognized at their fair value as of the date of acquisition. Following initial recognition, intangible assets are carried at acquisition date fair value less accumulated amortization and impairment losses, if any, and are amortized on a straight-line basis over the estimated useful life of the asset. We review goodwill for impairment annually on October 1st (beginning day of the fourth quarter) of each fiscal year or whenever events or changes in circumstances indicate that an impairment may exist. In the first nine months of 2022, there were no events or changes in circumstances that would have required an interim impairment test. In conducting our annual impairment test, we review qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If factors indicate that the fair value of the reporting unit is less than its carrying amount, we perform a quantitative assessment and the fair value of the reporting unit is determined by analyzing the expected present value of future cash flows. If the carrying value of the reporting unit continues to exceed its fair value, the fair value of the reporting unit’s goodwill is calculated and an impairment loss equal to the excess is recorded. We assess the impairment of intangible assets whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
Leases	Leases Prior to the adoption of Accounting Standards Codification (“ASC”) 842, Leases, on January 1, 2022 We categorized leases at their inception as either operating or capital. In the ordinary course of business, we enter into non-cancelable operating leases for office space. We recognized lease costs on a straight-line basis and treated lease incentives as a reduction of rent expense over the term of the agreement. The difference between cash rent payments and rent expense was recorded as a deferred rent liability, with the amount expected to be amortized within the next twelve months classified as a current liability. We subleased a portion of our office space and recognize rental income on a straight-line basis as an offset to rent expense within general and administrative costs. The difference between cash rent payments received and rental income was recorded within prepaid expenses and other current assets. Subsequent to the adoption of ASC 842 on January 1, 2022 We determine if an arrangement is a lease or contains a lease at inception. Our lease agreements are generally for office facilities, and the determination of whether such agreements contain leases generally does not require significant estimates or judgments. Our leases may also contain non-lease components such as payments of maintenance, utilities, and taxes, which we have elected to account for separately, as these amounts are readily determinable. At the commencement date of a lease, we recognize a liability to make lease payments and an asset representing the right to use the underlying asset during the lease term. The lease liability is measured at the present value of the minimum rental payments discounted using our incremental borrowing rate (“IBR”) over the lease term (or, if readily determinable, the rate implicit in the lease). The right-of-use asset is measured at cost, which includes the initial measurement of the lease liability and initial direct costs incurred and excludes lease incentives. We subleased a portion of our office space and recognize rental income on a straight-line basis as an offset to other leases costs, net within general and administrative expenses. The lease term used to measure right-of-use lease assets and lease liabilities may include renewal options which are deemed reasonably certain to be exercised. Operating lease costs are recognized on a straight-line basis over the lease term. Variable lease payments are expensed as incurred. Our leases do not contain any material residual value guarantees or material restrictive covenants.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) (“ASC 842”) , which requires lessees to recognize the following for all leases (with the exception of short-term leases) at the commencement date: (i) a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and (ii) a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Additional disclosures are required to allow financial statement users to assess the amount, timing, and uncertainty of cash flows arising from leasing activities. A modified retrospective transition approach is required for leases existing at the time of adoption. We adopted and began applying the standard on January 1, 2022 using the modified retrospective approach and applied it to all existing leases as of the adoption date. We will continue to present prior period amounts under ASC 840, Leases . In addition, we elected the package of practical expedients permitted under the transition guidance within the new standard which does not require us to reassess whether contracts that existed or expired prior to the adoption date contained an embedded lease, reassess historical lease classification, or evaluate initial direct costs for leases that were in effect at the adoption date. We did not elect the hindsight practical expedient related to determining the lease term. As a result of implementing this guidance, we recognized $20.6 million in operating lease right-of-use assets as of January 1, 2022, and derecognized $2.4 million of previously recognized deferred rent. We also recorded $2.5 million in current operating lease liabilities and $18.1 million in operating lease liabilities, net of current portion in our condensed consolidated balance sheet as of January 1, 2022. The adoption of ASC 842 did not result in a cumulative-effect adjustment on retained earnings. See “Note 11—Leases” for additional details. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which requires an entity to utilize the current expected credit loss (“CECL”) model to estimate its lifetime “expected credit loss” and record an allowance that, when deducted from the amortized cost basis of the financial asset, presents the net amount expected to be collected on the financial asset. The CECL model results in more timely recognition of credit losses. This guidance also requires new disclosures for financial assets measured at amortized cost, loans, and available-for-sale debt securities. We adopted this standard as of January 1, 2022. The adoption did not have a material impact on our condensed consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805)—Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which requires an acquirer to recognize and measure contract assets and contract liabilities in accordance with ASC Topic 606, Revenue from Contracts with Customers . Under prior guidance, an acquirer generally recognized assets acquired and liabilities assumed in a business combination, including contract assets and contract liabilities arising from revenue contracts with customers, at fair value on the acquisition date. ASU No. 2021-08 results in the acquirer recording acquired contract assets and liabilities on the same basis that would have been recorded by the acquiree before the acquisition under ASC Topic 606. ASU No. 2021-08 is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. We early adopted ASU No 2021-08 as of January 1, 2022 on a

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Rollforward of Allowance for Doubtful Accounts	The following summarizes our allowance for doubtful accounts activity (in thousands): September 30, 2022 2021 Beginning balance $ 657 $ 631 Bad debt expense 263 283 Writeoffs (308) (257) Ending balance $ 612 $ 657

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table disaggregates revenue by type (in thousands): Three Months Ended September 30, 2022 Platform Professional Total Timing of revenue recognition Transferred over time $ 23,919 $ 909 $ 24,828 Transferred at a point in time 22,438 — 22,438 Total revenue $ 46,357 $ 909 $ 47,266 Three Months Ended September 30, 2021 Platform Professional Total Timing of revenue recognition Transferred over time $ 17,046 $ 1,306 $ 18,352 Transferred at a point in time 19,038 — 19,038 Total revenue $ 36,084 $ 1,306 $ 37,390 Nine Months Ended September 30, 2022 Platform Professional Total Timing of revenue recognition Transferred over time $ 67,710 $ 3,262 $ 70,972 Transferred at a point in time 64,651 — 64,651 Total revenue $ 132,361 $ 3,262 $ 135,623 Nine Months Ended September 30, 2021 Platform Professional Total Timing of revenue recognition Transferred over time $ 47,902 $ 3,876 $ 51,778 Transferred at a point in time 57,631 — 57,631 Total revenue $ 105,533 $ 3,876 $ 109,409
Schedule of Current and Non-current Deferred Contract Costs	The following table summarizes the activity of current and non-current deferred contract costs (in thousands): Nine Months Ended September 30, 2022 2021 Beginning balance $ 6,183 $ 5,176 Capitalization of deferred contract costs 3,084 2,607 Amortization of deferred contract costs (2,547) (2,013) Ending balance $ 6,720 $ 5,770

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements, Nonrecurring	The following tables present the costs, net unrealized losses, and fair value by major security type for our investments as of September 30, 2022 and December 31, 2021 (in thousands): As of September 30, 2022 Cost Net Unrealized Losses Fair Value Cash and cash equivalents Short-term investments Long-term investments Cash $ 224,315 $ — $ 224,315 $ 224,315 $ — $ — Level 1: Money market funds 140,977 — 140,977 140,977 — — Commercial paper 20,617 (73) 20,544 905 19,639 — Subtotal 161,594 (73) 161,521 141,882 19,639 — Level 2: Certificates of deposit 32,857 (124) 32,733 — 32,733 — U.S. Government and agency securities 27,392 (86) 27,306 — 27,306 — Corporate bonds 23,421 (137) 23,284 202 22,278 804 Subtotal 83,670 (347) 83,323 202 82,317 804 Level 3: — — — — — — Total $ 469,579 $ (420) $ 469,159 $ 366,399 $ 101,956 $ 804 As of December 31, 2021 Cost Net Unrealized Losses Fair Value Cash and cash equivalents Short-term investments Long-term investments Cash $ 219,344 $ — $ 219,344 $ 219,344 $ — $ — Level 1: Money market funds 295,101 — 295,101 295,101 — — Total $ 514,445 $ — $ 514,445 $ 514,445 $ — $ —

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following (in thousands): Estimated Useful Life As of September 30, 2022 As of December 31, 2021 Computer and office equipment 3 - 5 $ 2,186 $ 1,800 Capitalized internal-use software 3 11,770 3,392 Furniture and fixtures 10 132 386 Leasehold improvements Shorter of estimated useful life or remaining term of lease 364 374 Total property and equipment 14,452 5,952 Less: accumulated depreciation and amortization of internal-use software (3,912) (2,648) Total property and equipment, net $ 10,540 $ 3,304

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the preliminary allocation of the purchase price to the fair value of the assets acquired and liabilities assumed of Omnivore as of March 4, 2022 (in thousands): Initial Fair Value Estimate Accounts receivable $ 451 Other current assets 148 Operating lease right-of-use asset 236 Property and equipment 24 Other assets, noncurrent 9 Customer relationships 1,290 Developed technology 4,410 Trademark 150 Goodwill 44,678 Accounts payable (198) Accrued expenses and other current liabilities (101) Unearned revenue (83) Operating lease liability, current (81) Operating lease liability, noncurrent (177) Deferred tax liability, net (1,421) Total purchase price, net of cash acquired and post-closing working capital adjustment $ 49,335
Business Combination, Transaction Costs	The transaction related expenses are recorded within the condensed consolidated statements of operations as follows (in thousands): Operating expenses: Sales and marketing $ 79 General and administrative 1,155 Total transaction costs $ 1,234

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table summarizes the changes in the carrying amount of goodwill (in thousands): Balance at December 31, 2021 $ 162,956 Adjustment to Wisely acquisition (94) Acquisition of Omnivore 44,678 Balance at September 30, 2022 $ 207,540
Schedule of Finite-Lived Intangible Assets	The gross book value and accumulated amortization of intangible assets, net, as of September 30, 2022 were as follows (in thousands): Weighted-average Remaining Useful Life (in years) Gross Carrying Value Accumulated Amortization Net Carrying Value Developed technology 5.2 $ 14,595 $ (1,985) $ 12,610 Customer relationships 7.2 10,921 (1,197) 9,724 Trademark 2.1 486 (132) 354 Balance at September 30, 2022 $ 26,002 $ (3,314) $ 22,688
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of September 30, 2022, estimated amortization related to the identifiable acquisition-related intangible assets expected to be recognized in future periods was as follows (in thousands): 2022 (remaining) $ 950 2023 3,967 2024 3,949 2025 3,813 2026 3,804 Thereafter 6,205 Total $ 22,688

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following (in thousands): As of September 30, 2022 As of December 31, 2021 Prepaid software licensing fees $ 2,466 $ 1,888 Prepaid insurance 504 1,298 Other 3,674 2,532 Total prepaid expenses and other current assets $ 6,644 $ 5,718

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilities (Tables)	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of September 30, 2022 As of December 31, 2021 Accrued delivery service partner fees $ 35,111 $ 35,441 Accrued compensation and benefits 6,036 4,189 Professional and consulting fees 709 1,806 Accrued taxes 1,261 1,538 Other 3,426 2,421 Total accrued expenses and other current liabilities $ 46,543 $ 45,395

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Schedule of Lease Costs	The elements of lease expense were as follows (in thousands): Three Months Ended Nine Months Ended 2022 2022 Operating lease costs $ 843 $ 2,513 Other lease income (87) (261) Total lease costs $ 756 $ 2,252 The weighted average remaining lease term and discount rate for the operating leases were as follows: As of September 30, Weighted average remaining lease term (years) 7.35 Weighted average discount rate 5.40%
Schedule of Payments Under Non-cancelable Operating Leases	As of September 30, 2022, the total remaining operating lease payments included in the measurement of lease liabilities were as follows (in thousands): 2022 (remaining) $ 907 2023 3,444 2024 2,877 2025 2,893 2026 2,960 Thereafter 10,114 Total future minimum lease payments 23,195 Less: imputed interest (4,201) Total $ 18,994
Schedule of Future Minimum Rental Payments for Operating Leases	As of December 31, 2021, our future minimum payments under non-cancelable leases for operating facilities as determined prior to the adoption of ASC 842 were as follows (in thousands): 2022 $ 3,559 2023 3,352 2024 2,780 2025 2,885 2026 2,960 Thereafter 10,113 Total $ 25,649

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Schedule of Common Stock Reserved for Future Issuance	Class A common stock and Class B common stock reserved for future issuance consisted of the following: As of September 30, As of December 31, Shares available for grant under employee stock purchase plan 5,145,300 3,760,115 Shares available for grant under stock option plan 22,597,825 18,994,572 Restricted stock units 4,710,098 1,082,980 Options issued and outstanding under stock option plan 31,960,236 36,716,816 Total common stock reserved for future issuance 64,413,459 60,554,483

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Restricted Stock Unit, Activity	The following summarizes the activity for the unvested RSUs during the nine months ended September 30, 2022: Shares Weighted- Unvested at December 31, 2021 1,082,980 $ 27.70 Granted 4,699,191 15.48 Vested (503,371) 20.40 Forfeited and canceled (568,702) 19.80 Unvested at September 30, 2022 4,710,098 $ 17.24
Schedule of Stock Options	The following summarizes our stock option activity for the nine months ended September 30, 2022 (in thousands, except share and per share amounts): Number of Weighted- Weighted- Aggregate As of December 31, 2021 36,716,816 $ 3.55 5.76 $ 633,730 Granted 1,100,118 14.72 Exercised (4,915,101) 1.56 Forfeited (941,597) 6.77 Vested and expected to vest as of September 30, 2022 31,960,236 $ 4.15 5.32 $ 144,435 Exercisable as of September 30, 2022 24,706,582 $ 2.73 4.47 $ 134,287
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value	The following table summarizes the weighted-average grant date fair value of options granted, intrinsic value of options exercised, and fair value of options vested for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share amounts): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Weighted-average grant date fair value of options granted $ 4.45 N/A $ 4.87 $ 10.70 Intrinsic value of options exercised $ 18,074 $ 97,370 $ 59,212 $ 169,450 Total fair value of options vested $ 6,027 $ 10,709 $ 20,604 $ 29,355
Schedule of Black-Scholes Option Pricing Model Assumptions	We estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted-average assumptions: Three Months Ended Nine Months Ended 2022 2021 2022 2021 Expected term (in years) 6.00 N/A 5.24 - 6.00 5.48 - 6.07 Volatility 36% N/A 32% - 36% 52% - 65% Risk-free interest rate 2.87% N/A 1.62% - 2.87% 0.50% - 1.06% Dividend yield 0% N/A 0% 0% Fair value of underlying common stock $11.07 N/A $11.07 - $15.75 $16.78 - $30.02
Schedule of Stock-based Compensation By Statement of Operations Line Item	The classification of stock-based compensation expense, which includes expense for stock options, RSUs, SARs, and ESPP charges, by line item within the condensed consolidated statements of operations was as follows (in thousands): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Cost of revenue - platform $ 1,367 $ 762 $ 4,269 $ 1,942 Cost of revenue - professional services and other 167 116 565 362 Research and development 3,571 2,570 10,382 8,522 General and administrative 5,442 3,907 15,567 12,002 Sales and marketing 1,372 512 4,321 1,436 Total stock-based compensation expense $ 11,919 $ 7,867 $ 35,104 $ 24,264

Net Loss per Share Attributab_2

Net Loss per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Net Loss Available to Common Stockholders	A reconciliation of net loss available to common stockholders and the number of shares in the calculation of basic net loss per share is as follows (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss $ (14,560) $ (11,308) $ (37,742) $ (40,202) Less: accretion of redeemable convertible preferred stock to redemption value — — — (14) Net loss attributable to Class A and Class B common stockholders—basic and diluted $ (14,560) $ (11,308) $ (37,742) $ (40,216) Three Months Ended Nine Months Ended 2022 2021 2022 2021 Denominator: Weighted-average Class A and Class B common shares outstanding—basic and diluted 162,364,654 148,452,987 160,667,412 113,451,378 Net loss per share attributable to Class A and Class B common stockholders––basic and diluted $ (0.09) $ (0.08) $ (0.23) $ (0.35)
Schedule of Anti-dilutive Securities Excluded from Loss per Share	The following participating securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Outstanding stock options 31,960,236 39,815,982 31,960,236 39,815,982 Outstanding restricted stock units 4,710,098 155,422 4,710,098 155,422 Outstanding shares estimated to be purchased under ESPP 125,128 143,815 125,128 143,815 Total 36,795,462 40,115,219 36,795,462 40,115,219

Business (Details)

Business (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended	9 Months Ended
	Mar. 19, 2021	Mar. 18, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Class of Stock [Line Items]
Stock issuance costs				$ 423	$ 4,118
Issuance of preferred stock on exercises of warrants (in shares)			1,681,848
IPO
Class of Stock [Line Items]
Stock issuance costs	$ 6,600
Common Class A | IPO
Class of Stock [Line Items]
Shares issued and sold (in shares)	20,700,000
Public offing price per share (in USD per share)	$ 25
Proceeds from public offering	$ 485,500
Redeemable Convertible Preferred Stock
Class of Stock [Line Items]
Issuance of preferred stock on exercises of warrants (in shares)		1,682,847
Common Class B
Class of Stock [Line Items]
Shares converted (in shares)		100,196,780
Common Class B | Stock Appreciation Rights (SARs)
Class of Stock [Line Items]
Shares issued upon vesting and settlement (in shares)		1,642,570

Significant Accounting Polici_4

Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Jan. 01, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Unbilled receivables	$ 600		$ 600			$ 4,100
Operating lease right-of-use asset	14,568		14,568		$ 20,600	0
Deferred rent					2,400
Operating lease liability, current	$ 2,666		$ 2,666		2,500	$ 0
Operating lease, liability, non current, net of current					$ 18,100
Revenue Benchmark | Customer Concentration Risk | Largest Customer
Property, Plant and Equipment [Line Items]
Concentration risk	12%	16%	12%	19%

Significant Accounting Polici_5

Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning allowance	$ 657	$ 631
Bad debt expense	263	283
Writeoffs	(308)	(257)
Ending allowance	$ 612	$ 657

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenue	$ 47,266	$ 37,390	$ 135,623	$ 109,409
Transferred over time
Disaggregation of Revenue [Line Items]
Total revenue	24,828	18,352	70,972	51,778
Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	22,438	19,038	64,651	57,631
Platform
Disaggregation of Revenue [Line Items]
Total revenue	46,357	36,084	132,361	105,533
Platform | Transferred over time
Disaggregation of Revenue [Line Items]
Total revenue	23,919	17,046	67,710	47,902
Platform | Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	22,438	19,038	64,651	57,631
Professional Services and Other
Disaggregation of Revenue [Line Items]
Total revenue	909	1,306	3,262	3,876
Professional Services and Other | Transferred over time
Disaggregation of Revenue [Line Items]
Total revenue	909	1,306	3,262	3,876
Professional Services and Other | Transferred at a point in time
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 0	$ 0	$ 0

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract assets	$ 1		$ 1
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized previously unearned	1.2	$ 0.4
Remaining performance obligations	$ 40.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Percent of remaining performance obligation expected to be recognized (as a percent)	45%
Revenue, remaining performance obligation, period (in months)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period (in months)	24 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period (in months)	48 months

Revenue Recognition - Deferred

Revenue Recognition - Deferred Contract Costs (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Capitalized Contract Cost [Roll Forward]
Capitalized contract cost balance at beginning of period	$ 6,183	$ 5,176
Capitalization of deferred contract costs	3,084	2,607
Amortization of deferred contract costs	(2,547)	(2,013)
Capitalized contract cost balance at end of period	$ 6,720	$ 5,770

Fair Value Measurement - Amorti

Fair Value Measurement - Amortized Cost and Fair Value (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-Sale [Line Items]
Cost	$ 469,579	$ 514,445
Net Unrealized Losses	(420)	0
Fair Value	469,159	514,445
Cash and cash equivalents	366,399	514,445
Short-term investments	101,956	0
Long-term investments	804	0
Fair Value, Inputs, Level 1 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	161,594
Net Unrealized Losses	(73)	0
Fair Value	161,521	295,101
Cash and cash equivalents	141,882	295,101
Short-term investments	19,639	0
Long-term investments	0	0
Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	83,670
Net Unrealized Losses	(347)
Fair Value	83,323
Cash and cash equivalents	202
Short-term investments	82,317
Long-term investments	804
Fair Value, Inputs, Level 3 | Fair Value, Nonrecurring
Debt Securities, Available-for-Sale [Line Items]
Cost	0
Net Unrealized Losses	0
Fair Value	0
Cash and cash equivalents	0
Short-term investments	0
Long-term investments	0
Cash
Debt Securities, Available-for-Sale [Line Items]
Cost	224,315	219,344
Net Unrealized Losses	0	0
Fair Value	224,315	219,344
Cash and cash equivalents	224,315	219,344
Short-term investments	0	0
Long-term investments	0	0
Money market funds | Fair Value, Inputs, Level 1 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	140,977	$ 295,101
Net Unrealized Losses	0
Fair Value	140,977
Cash and cash equivalents	140,977
Short-term investments	0
Long-term investments	0
Commercial paper | Fair Value, Inputs, Level 1 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	20,617
Net Unrealized Losses	(73)
Fair Value	20,544
Cash and cash equivalents	905
Short-term investments	19,639
Long-term investments	0
Certificates of deposit | Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	32,857
Net Unrealized Losses	(124)
Fair Value	32,733
Cash and cash equivalents	0
Short-term investments	32,733
Long-term investments	0
U.S. Government and agency securities | Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	27,392
Net Unrealized Losses	(86)
Fair Value	27,306
Cash and cash equivalents	0
Short-term investments	27,306
Long-term investments	0
Corporate bonds | Fair Value, Inputs, Level 2 | Fair Value, Recurring
Debt Securities, Available-for-Sale [Line Items]
Cost	23,421
Net Unrealized Losses	(137)
Fair Value	23,284
Cash and cash equivalents	202
Short-term investments	22,278
Long-term investments	$ 804

Fair Value Measurement - Narrat

Fair Value Measurement - Narrative (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Aug. 31, 2022	Sep. 30, 2022
Debt Securities, Available-for-Sale [Line Items]
Operating Lease, Impairment Loss	$ 2.2	$ 2.3

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 14,452		$ 14,452		$ 5,952
Less: accumulated depreciation and amortization of internal-use software		(3,912)		(3,912)		(2,648)
Total property and equipment, net		10,540		10,540		3,304
Depreciation		700	$ 300	1,500	$ 800
Impairment of leasehold	$ 100	100		100
Computer and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross		2,186		$ 2,186		1,800
Computer and office equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in Years)				3 years
Computer and office equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in Years)				5 years
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in Years)				3 years
Property and equipment, gross		11,770		$ 11,770		3,392
Non-cash impairment charges				$ 500
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Useful Life (in Years)				10 years
Property and equipment, gross		132		$ 132		386
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross		$ 364		$ 364		$ 374

Acquisitions - Additional Infor

Acquisitions - Additional Information (Details)			9 Months Ended
	Mar. 04, 2022 USD ($)	Nov. 04, 2021 USD ($) $ / shares shares	Sep. 30, 2022 USD ($) shares	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($)
Asset Acquisition [Line Items]
Goodwill			$ 207,540,000		$ 162,956,000
Acquisition, net of cash acquired			$ 49,241,000	$ 0
SARs granted (in shares) | shares			1,100,118
Adjustment to Wisely acquisition			$ (94,000)
Omnivore Technologies, Inc.
Asset Acquisition [Line Items]
Business combination consideration transferred	$ 49,300,000
Goodwill	44,678,000
Goodwill, deductible for tax purposes	$ 0
Total transaction costs			1,234,000
Omnivore Technologies, Inc. | Customer relationships | Discount Rate
Asset Acquisition [Line Items]
Intangible assets, measurement input (as a percent)	0.110
Omnivore Technologies, Inc. | Developed technology | Discount Rate
Asset Acquisition [Line Items]
Intangible assets, measurement input (as a percent)	0.110
Omnivore Technologies, Inc. | Developed technology | Pre Tax Royalty Rate
Asset Acquisition [Line Items]
Intangible assets, measurement input (as a percent)	0.200
Omnivore Technologies, Inc. | Trademark | Discount Rate
Asset Acquisition [Line Items]
Intangible assets, measurement input (as a percent)	0.110
Omnivore Technologies, Inc. | Trademark | Pre Tax Royalty Rate
Asset Acquisition [Line Items]
Intangible assets, measurement input (as a percent)	0.010
Wisely Inc.
Asset Acquisition [Line Items]
Business combination consideration transferred		$ 177,800,000
Total transaction costs			200,000
Acquisition, net of cash acquired		75,200,000
Issuance of Class A common stock		96,600,000
Fair value of substituted stock options		$ 5,900,000
Business acquisition, share price (usd per share) | $ / shares		$ 27.93
Business acquisition, equity interest issued or issuable, number of shares (in shares) | shares		3,500,000
SARs granted (in shares) | shares		200,000
Adjustment to Wisely acquisition			$ (100,000)

Acquisitions - Allocation (Deta

Acquisitions - Allocation (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Mar. 04, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 207,540		$ 162,956
Omnivore Technologies, Inc.
Business Acquisition [Line Items]
Accounts receivable		$ 451
Other current assets		148
Operating lease right-of-use asset		236
Property and equipment		24
Other assets, noncurrent		9
Goodwill		44,678
Accounts payable		(198)
Accrued expenses and other current liabilities		(101)
Unearned revenue		(83)
Operating lease liability, current		(81)
Operating lease liability, noncurrent		(177)
Deferred tax liability, net		(1,421)
Total purchase price, net of cash acquired and post-closing working capital adjustment		49,335
Omnivore Technologies, Inc. | Customer relationships
Business Acquisition [Line Items]
Intangible assets		1,290
Omnivore Technologies, Inc. | Developed technology
Business Acquisition [Line Items]
Intangible assets		4,410
Omnivore Technologies, Inc. | Trademark
Business Acquisition [Line Items]
Intangible assets		$ 150

Acquisitions - Transaction Cost

Acquisitions - Transaction Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Asset Acquisition [Line Items]
Sales and marketing	$ 7,923	$ 4,728	$ 24,890	$ 12,265
General and administrative	$ 20,894	$ 21,270	56,090	$ 53,034
Omnivore Technologies, Inc.
Asset Acquisition [Line Items]
Sales and marketing			79
General and administrative			1,155
Total transaction costs			$ 1,234

Acquisitions - Purchase Conside

Acquisitions - Purchase Consideration (Details) - USD ($) $ in Thousands		9 Months Ended
	Nov. 04, 2021	Sep. 30, 2022	Sep. 30, 2021
Asset Acquisition [Line Items]
Acquisition, net of cash acquired		$ 49,241	$ 0
Wisely Inc.
Asset Acquisition [Line Items]
Acquisition, net of cash acquired	$ 75,200
Issuance of Class A common stock	96,600
Fair value of substituted stock options	5,900
Total purchase price, net of cash acquired	$ 177,800

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Goodwill [Roll Forward]
Balance as of the beginning of the period	$ 162,956
Adjustment to Wisely acquisition	(94)
Acquisition of Omnivore	44,678
Balance as of the end of the period	$ 207,540

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Gross Book Value (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 26,002
Accumulated Amortization	(3,314)
Net Carrying Value	$ 22,688	$ 19,635
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	5 years 2 months 12 days
Gross Carrying Value	$ 14,595
Accumulated Amortization	(1,985)
Net Carrying Value	$ 12,610
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	7 years 2 months 12 days
Gross Carrying Value	$ 10,921
Accumulated Amortization	(1,197)
Net Carrying Value	$ 9,724
Trademark
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	2 years 1 month 6 days
Gross Carrying Value	$ 486
Accumulated Amortization	(132)
Net Carrying Value	$ 354

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 1	$ 2.8

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Future Amortization (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (remaining)	$ 950
2023	3,967
2024	3,949
2025	3,813
2026	3,804
Thereafter	6,205
Total	$ 22,688

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid software licensing fees	$ 2,466	$ 1,888
Prepaid insurance	504	1,298
Other	3,674	2,532
Total prepaid expenses and other current assets	$ 6,644	$ 5,718

Accrued Expenses and Other Li_3

Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued delivery service partner fees	$ 35,111	$ 35,441
Accrued compensation and benefits	6,036	4,189
Professional and consulting fees	709	1,806
Accrued taxes	1,261	1,538
Other	3,426	2,421
Total accrued expenses and other current liabilities	$ 46,543	$ 45,395

Line of Credit (Details)

Line of Credit (Details) - USD ($)	Jun. 10, 2022	Sep. 30, 2022
Revolving Credit Facility | Letter of Credit
Debt Instrument [Line Items]
Letters of credit outstanding, amount		$ 1,400,000
Revolving Credit Facility | Line of Credit
Debt Instrument [Line Items]
Outstanding balance of credit		0
Second Amended Credit Facility | Line of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 70,000,000
Line of credit facility, accordion feature, increase limit	$ 125,000,000
Fee on outstanding principal	1%
Liquidity event		3,500,000
Debt instrument, liquidity event, term	24 months
Second Amended Credit Facility | Line of Credit | Triggering Event One
Debt Instrument [Line Items]
Success triggering fee	$ 800,000
Second Amended Credit Facility | Line of Credit | Triggering Event Two
Debt Instrument [Line Items]
Success triggering fee	600,000
Second Amended Credit Facility | Line of Credit | Triggering Event Three
Debt Instrument [Line Items]
Success triggering fee	400,000
Second Amended Credit Facility | Line of Credit | Triggering Event Four
Debt Instrument [Line Items]
Success triggering fee	200,000
Second Amended Credit Facility | Line of Credit | Triggering Event Five
Debt Instrument [Line Items]
Success triggering fee	$ 0
Second Amended Credit Facility | Prime Rate | Line of Credit
Debt Instrument [Line Items]
Interest rate	3.25%
Second Amended Credit Facility | Prime Rate | Line of Credit | Minimum
Debt Instrument [Line Items]
Basis spread	0.25%
Second Amended Credit Facility | Prime Rate | Line of Credit | Maximum
Debt Instrument [Line Items]
Basis spread	3.50%
DoorDash Agreement | Letter of Credit
Debt Instrument [Line Items]
Current borrowing capacity		43,600,000
Letter of credit issued amount		25,000,000
Amounts drawn against letter of credit		$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 31, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Impairment charge	$ 2,200	$ 2,300
Impairment of leasehold	100	100		$ 100
Professional fees	$ 900
Rent expense			$ 800		$ 2,500
Rental income		$ 87	$ 100	261	$ 300
Operating lease, payments				$ 2,700

Leases - Lease Expenses (Detail

Leases - Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Leases [Abstract]
Operating lease costs	$ 843		$ 2,513
Other lease income	(87)	$ (100)	(261)	$ (300)
Total lease costs	$ 756		$ 2,252

Leases - Maturities (Details)

Leases - Maturities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
2022 (remaining)	$ 907
2023	3,444
2024	2,877
2025	2,893
2026	2,960
Thereafter	10,114
Total future minimum lease payments	23,195
Less: imputed interest	(4,201)
Total	$ 18,994

Leases - Weighted Average (Deta

Leases - Weighted Average (Details)	Sep. 30, 2022
Leases [Abstract]
Weighted average remaining lease term (years)	7 years 4 months 6 days
Weighted average discount rate	5.40%

Leases - Maturities Prior to Ad

Leases - Maturities Prior to Adoption (Details) $ in Thousands	Dec. 31, 2021 USD ($)
Leases [Abstract]
2022	$ 3,559
2023	3,352
2024	2,780
2025	2,885
2026	2,960
Thereafter	10,113
Total	$ 25,649

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details)		1 Months Ended	3 Months Ended			9 Months Ended
	Mar. 05, 2021 vote $ / shares shares	Mar. 31, 2021 shares	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Sep. 07, 2022 USD ($)	Dec. 31, 2021 $ / shares shares
Class of Stock [Line Items]
Stock split ratio	17
Preferred stock, shares authorized (in shares)	20,000,000		20,000,000			20,000,000			20,000,000
Preferred stock, par value (in USD per share) | $ / shares	$ 0.001		$ 0.001			$ 0.001			$ 0.001
Issuance of common stock in connection with charitable donation | $			$ 1,406,000	$ 7,982,000	$ 5,125,000
Common Class A
Class of Stock [Line Items]
Common stock authorized (in shares)	1,700,000,000		1,700,000,000			1,700,000,000			1,700,000,000
Number of votes per share of common stock | vote	1
Outstanding shares reclassified (in shares)			105,063,706			105,063,706			78,550,530
Repurchase of common stock authorised amount | $								$ 100,000,000
Approved shares for issuance in connection with charitable donation (in shares)		1,729,189
Issuance of common stock in connection with charitable donation (in shares)			172,918	172,918		172,918	345,836
Issuance of common stock in connection with charitable donation | $			$ 1,400,000	$ 8,000,000		$ 1,400,000	$ 13,100,000
Donated shares (in shares)			518,754			518,754
Expected percent of remaining shares to be donated			10%			10%
Common Class B
Class of Stock [Line Items]
Common stock authorized (in shares)	185,000,000		185,000,000			185,000,000			185,000,000
Number of votes per share of common stock | vote	10
Outstanding shares reclassified (in shares)	124,012,926		58,421,140			58,421,140			79,149,659

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock Reserved for Future Issuance (Details) - shares	Sep. 30, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Common stock reserved for future issuance (in shares)	64,413,459	60,554,483
Shares available for grant under employee stock purchase plan
Class of Stock [Line Items]
Common stock reserved for future issuance (in shares)	5,145,300	3,760,115
Outstanding stock options
Class of Stock [Line Items]
Common stock reserved for future issuance (in shares)	22,597,825	18,994,572
Restricted stock units
Class of Stock [Line Items]
Common stock reserved for future issuance (in shares)	4,710,098	1,082,980
Options issued and outstanding under stock option plan
Class of Stock [Line Items]
Common stock reserved for future issuance (in shares)	31,960,236	36,716,816

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Thousands				3 Months Ended		9 Months Ended
	Mar. 18, 2021	Mar. 13, 2021	Mar. 05, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding shares exercised early (in shares)				56,508		56,508		120,088
Liability recorded for unvested shares exercised early				$ 200		$ 200
Common shares authorized for issuance (in shares)				29,445,392		29,445,392		20,615,612
Common stock reserved for future issuance (in shares)				64,413,459		64,413,459		60,554,483
SARs granted (in shares)						1,100,118
Stock-based compensation expense				$ 11,919	$ 7,867	$ 35,104	$ 24,264
Future stock-based compensation for unvested options granted and outstanding				$ 49,700		$ 49,700
Share-Based Payment Arrangement, Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period						10 years
Percent determining major stockholder						10%
Percentage of fair value of shares at grant date to determine purchase price						100%
Vesting period (in years)						4 years
Common stock reserved for future issuance (in shares)				22,597,825		22,597,825		18,994,572
Weighted-average recognition period						2 years 25 days
Share-Based Payment Arrangement, Option | 10% Stockholder
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period						5 years
Incentive Stock Option (ISO) And Nonqualified Stock Option (NSO) | 10% Stockholder
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of fair value of shares at grant date to determine purchase price						110%
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
RSUs granted (in shares)						4,699,191
Fair value of awards vested during the period						$ 5,100
Unrecognized compensation expense				$ 73,600		$ 73,600
Weighted-average recognition period						3 years 3 months 3 days
Restricted stock units | Board Of Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years)		3 years
Value of awards granted		$ 300
Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SARs granted (in shares)						0	0
Stock-based compensation expense							$ 2,800
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense						$ 1,200
Minimum | Incentive Stock Option (ISO) And Nonqualified Stock Option (NSO)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percent determining major stockholder						10%
Common Class B | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued upon vesting and settlement (in shares)	1,642,570
Common Class A | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of fair value of shares at grant date to determine purchase price			85%
Common shares authorized for issuance (in shares)			3,900,000
Annual percent increase of number of shares reserved for issuance			1%
Annual increase of number of shares reserved for issuance (in shares)			11,700,000
Percentage of earnings applied to purchase of stock under ESPP			15%

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of RSUs (Details) - Restricted stock units	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Shares
RSUs unvested at beginning of period (in shares) | shares	1,082,980
RSUs granted (in shares) | shares	4,699,191
RSUs vested (in shares) | shares	(503,371)
RSUs forfeited and canceled (in shares) | shares	(568,702)
RSUs unvested at end of period (in shares) | shares	4,710,098
Weighted- Average Grant Date Fair Value
Weighted-average grant date fair value of RSUs unvested at beginning of period (in USD per share) | $ / shares	$ 27.70
Weighted-average grant date fair value of RSUs granted (in USD per share) | $ / shares	15.48
Weighted-average grant date fair value of RSUs vested (in USD per share) | $ / shares	20.40
Weighted-average grant date fair value of RSUs forfeited and canceled (in USD per share) | $ / shares	19.80
Weighted-average grant date fair value of RSUs unvested at end of period (in USD per share) | $ / shares	$ 17.24

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Stock Options (Details) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Number of options outstanding
Options outstanding at beginning of period (in shares) | shares	36,716,816
Awards granted and awarded (in shares) | shares	1,100,118
Options exercised (in shares) | shares	(4,915,101)
Options forfeited (in shares) | shares	(941,597)
Options outstanding at end of period (in shares) | shares	31,960,236	36,716,816
Options vested and expected to vest (in shares) | shares	31,960,236
Options exercisable (in shares) | shares	24,706,582
Weighted- average exercise price
Weighted-average exercise price of options outstanding at beginning of period (in USD per share) | $ / shares	$ 3.55
Weighted-average exercise price of options granted (in USD per share) | $ / shares	14.72
Weighted-average exercise price of options exercised (in USD per share) | $ / shares	1.56
Weighted-average exercise price of options forfeited (in USD per share) | $ / shares	6.77
Weighted-average exercise price of options outstanding at end of period (in USD per share) | $ / shares	4.15	$ 3.55
Weighted-average exercise price of options vested and expected to vest (in USD per share) | $ / shares	4.15
Weighted-average exercise price of options exercisable (in USD per share) | $ / shares	$ 2.73
Weighted-average remaining contractual term of options outstanding (in years)		5 years 9 months 3 days
Weighted-average remaining contractual term of options vested and expected to vest (in years)	5 years 3 months 25 days
Weighted-average remaining contractual term of options exercisable (in years)	4 years 5 months 19 days
Aggregate intrinsic value of shares outstanding | $	$ 144,435	$ 633,730
Aggregate intrinsic value of shares exercisable | $	$ 134,287

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Additional Stock Option Disclosures (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-Based Payment Arrangement [Abstract]
Weighted-average grant date fair value of options granted (in USD per share)	$ 4.45		$ 4.87	$ 10.70
Aggregate intrinsic value of options exercised	$ 18,074	$ 97,370	$ 59,212	$ 169,450
Grant date fair value of options vested	$ 6,027	$ 10,709	$ 20,604	$ 29,355

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of Black-Scholes Assumptions (Details) - Share-Based Payment Arrangement, Option - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years
Volatility	36%
Risk-free interest rate	2.87%
Minimum risk-free interest rate		1.62%	0.50%
Maximum risk-free interest rate		2.87%	1.06%
Dividend yield	0%	0%	0%
Fair value of underlying common stock (in USD per share)	$ 11.07	$ 11.07
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)		5 years 2 months 26 days	5 years 5 months 23 days
Volatility		32%	52%
Fair value of underlying common stock (in USD per share)	11.07	$ 11.07	$ 16.78
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)		6 years	6 years 25 days
Volatility		36%	65%
Fair value of underlying common stock (in USD per share)	$ 15.75	$ 15.75	$ 30.02

Stock-Based Compensation - Sc_5

Stock-Based Compensation - Schedule of Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 11,919	$ 7,867	$ 35,104	$ 24,264
Cost of Sales | Platform
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	1,367	762	4,269	1,942
Cost of Sales | Professional services and other
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	167	116	565	362
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	3,571	2,570	10,382	8,522
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	5,442	3,907	15,567	12,002
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 1,372	$ 512	$ 4,321	$ 1,436

Warrants (Details)

Warrants (Details) - USD ($) $ in Thousands		3 Months Ended			9 Months Ended
	Mar. 18, 2021	Sep. 30, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Class of Warrant or Right [Line Items]
Shares exercised (in shares)				1,681,848
Change in fair value of warrants		$ 0	$ 0		$ 0	$ 18,930
Redeemable Convertible Preferred Stock
Class of Warrant or Right [Line Items]
Shares exercised (in shares)	1,682,847
Common Class B
Class of Warrant or Right [Line Items]
Shares converted (in shares)	100,196,780
Redeemable Convertible Preferred Stock Warrants
Class of Warrant or Right [Line Items]
Change in fair value of warrants						$ 18,900

Income Taxes (Details)

Income Taxes (Details)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	2.61%	(0.27%)

Net Loss per Share Attributab_3

Net Loss per Share Attributable to Common Stockholders - Schedule of EPS (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss	$ (14,560)	$ (11,673)	$ (11,509)	$ (11,308)	$ (2,437)	$ (26,457)	$ (37,742)	$ (40,202)
Less: accretion of redeemable convertible preferred stock to redemption value	0			0			0	(14)
Net loss attributable to Class A and Class B common stockholders	(14,560)			(11,308)			(37,742)	(40,216)
Net loss attributable to Class A and Class B common stockholders - diluted	$ (14,560)			$ (11,308)			$ (37,742)	$ (40,216)
Denominator:
Weighted-average Class A and Class B common shares outstanding - basic (in shares)	162,364,654			148,452,987			160,667,412	113,451,378
Weighted-average Class A and Class B common shares outstanding - diluted (in shares)	162,364,654			148,452,987			160,667,412	113,451,378
Net loss per share attributable to Class A and Class B common stockholders - basic (in shares)	$ (0.09)			$ (0.08)			$ (0.23)	$ (0.35)
Net loss per share attributable to Class A and Class B common stockholders - diluted (in shares)	$ (0.09)			$ (0.08)			$ (0.23)	$ (0.35)

Net Loss per Share Attributab_4

Net Loss per Share Attributable to Common Stockholders - Antidilutive Securities (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of net loss per share (in shares)	36,795,462	40,115,219	36,795,462	40,115,219
Outstanding stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of net loss per share (in shares)	31,960,236	39,815,982	31,960,236	39,815,982
Outstanding restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of net loss per share (in shares)	4,710,098	155,422	4,710,098	155,422
Outstanding shares estimated to be purchased under ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of net loss per share (in shares)	125,128	143,815	125,128	143,815